Vocal cord dysfunction

VOCALCORDDYS

human african trypanosomiasis: A parasitic disorder caused by protozoa of the Trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of Sub-Saharan Africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J38 Cause of death: ICD-10 — J38 2 out of 7 registries used, show all original rules.	7176
4. Check minimum number of events None	7176
5. Include endpoints None	7176
6. Filter based on genotype QC (FinnGen only)	7176

Control definitions (FinnGen only)

Control exclude: ASTHMA_COMORB

Extra metadata

First used in FinnGen datafreeze: DF9
Parent code in ICD-10: J38

NAME	VOCALCORDDYS
CONTROL_EXCLUDE	ASTHMA_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J38
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J38
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vocal cord dysfunction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42520	24121	18181
Only index persons	38879	22738	16141
Unadjusted period prevalence (%)
Whole population	0.61	0.69	0.51
Only index persons	0.74	0.84	0.62
Median age at first event (years)
Whole population	52.45	51.19	53.98
Only index persons	51.86	50.83	53.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7176	4452	2724
Unadjusted period prevalence (%)	1.40	1.52	1.20
Median age at first event (years)	54.61	51.30	60.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6369: Matched controls
60112

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UDQ12

NOMESCO Finland

Flexible laryngoscopy

28.9

323.0

1822

822

R06.0

ICD-10 Finland

Dyspnoea

4.4

323.0

1763

4786

J37.0

ICD-10 Finland

Chronic laryngitis

30.9

323.0

1052

382

R49.01

ICD-10 Finland

Functional dysphonia

16.7

323.0

758

482

103

Kela drug reimbursment

Diabetes, insulin-treated

796.0

323.0

1000

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

432

207

Kela drug reimbursment

Chronic arrhythmias

104.0

323.0

508

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

38.1

323.0

635

174

C03CA01

ATC

furosemide; systemic

4.9

323.0

1308

3003

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

11.6

323.0

942

888

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

51.0

323.0

1181

267

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

14.9

323.0

761

541

215

Kela drug reimbursment

Diabetes, non-insulin-treated

5028.4

323.0

936

A10BA02

ATC

metformin; oral

40.0

323.0

1060

298

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

110.4

323.0

375

H25.1

ICD-10 Finland

Senile nuclear cataract

31.4

323.0

885

307

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.2

323.0

2008

4895

J38.2

ICD-10 Finland

Nodules of vocal cords

2357.7

323.0

702

J38.7

ICD-10 Finland

Other diseases of larynx

388.3

323.0

636

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

33.9

323.0

886

285

H02AB06

ATC

prednisolone; systemic

3.5

323.0

3268

13951

A02BC05

ATC

esomeprazole; systemic

3.5

323.0

3092

12646

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

323.0

2897

10045

R49.08

ICD-10 Finland

Other specified dysphonia

25.5

323.0

688

284

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

+∞

323.0

1094

H25.8

ICD-10 Finland

Other senile cataract

62.0

323.0

407

R03AC02

ATC

salbutamol; inhalant

2.8

323.0

3627

19072

C01DA14

ATC

isosorbide mononitrate; oral

17.5

323.0

557

326

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

176.0

323.0

967

C07AB07

ATC

bisoprolol; oral

4.0

323.0

2463

8147

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

9394.5

323.0

2516

T90

ICPC

Diabetes non-insulin dependent

15.3

323.0

910

647

I48

ICD-10 Finland

Atrial fibrillation and flutter

65.8

323.0

844

139

I25.1

ICD-10 Finland

Atherosclerotic heart disease

105.4

323.0

861

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

6.8

323.0

967

1536

J38.4

ICD-10 Finland

Oedema of larynx

1081.4

323.0

622

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

17.8

323.0

659

387

A02BC02

ATC

pantoprazole; systemic

3.2

323.0

4252

22932

UDQ22

NOMESCO Finland

Microlaryngoscopy

95.8

323.0

462

J38.3

ICD-10 Finland

Other diseases of vocal cords

1069.5

323.0

1346

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

419.6

323.0

496

E11

ICD-10 Finland

Type 2 diabetes mellitus

16.1

319.5

542

344

A10BH01

ATC

sitagliptin; oral

390.4

310.8

317

B01AC04

ATC

clopidogrel; oral

10.8

310.4

633

605

R4130

NOMESCO Finland

Speech therapy

22.9

307.4

460

203

WX100

NOMESCO Finland

Conjunctival surface anesthesia

22.8

304.3

456

202

J38.5

ICD-10 Finland

Laryngeal spasm

994.9

303.8

302

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

68.2

302.2

356

R13

ICD-10 Finland

Dysphagia

8.4

293.1

691

853

WX408

NOMESCO Finland

General anesthesy, balanced

3.1

288.4

2057

8024

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

704.1

285.4

286

H26.4

ICD-10 Finland

After-cataract

85.0

284.1

325

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

280.4

878

1615

R06.5

ICD-10 Finland

Mouth breathing

15.7

277.3

475

307

J45.9

ICD-10 Finland

Asthma, unspecified

3.9

275.0

1315

3744

AA1AD

NOMESCO Finland

CT of head and brain

3.9

273.2

1309

3731

A10AE04

ATC

insulin glargine; parenteral

203.0

272.7

288

Z50.5

ICD-10 Finland

Speech therapy

27.6

271.2

384

139

EP1AE

NOMESCO Finland

Neck ultrasound examination

6.9

268.9

725

1092

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.4

264.7

1097

2728

SPAT1262

SPAT

Handing over of treatment supplies

6.3

263.8

767

1279

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.3

259.9

751

1241

Z96.1

ICD-10 Finland

Presence of intraocular lens

13.3

254.7

468

356

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1215.1

250.0

248

R03BB04

ATC

tiotropium bromide; inhalant

6.1

249.9

748

1291

BAA60

NOMESCO Finland

Total thyroidectomy

10.8

249.5

507

476

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.9

249.0

567

655

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

80.7

248.3

286

Z01.8

ICD-10 Finland

Other specified special examinations

3.3

247.0

1495

5096

B01AA03

ATC

warfarin; systemic

5.6

246.6

790

1482

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.1

245.8

734

1262

N02AX02

ATC

tramadol; systemic, rectal

2.6

244.1

2595

12661

CJB10

NOMESCO Finland

Laser discission of secondary cataract

93.8

244.1

276

I50.9

ICD-10 Finland

Heart failure, unspecified

11.9

242.8

469

397

R07.4

ICD-10 Finland

Chest pain, unspecified

3.2

241.1

1506

5239

N03AX16

ATC

pregabalin; oral

3.2

234.4

1522

5432

A02BC03

ATC

lansoprazole; oral

2.8

233.8

1888

7789

H03AA01

ATC

levothyroxine sodium; systemic

2.9

232.8

1726

6737

G47.3

ICD-10 Finland

Sleep apnoea

3.6

231.2

1202

3620

N02BE01

ATC

paracetamol; systemic, rectal

2.8

229.0

5302

38474

A02BC01

ATC

omeprazole; systemic

2.9

227.3

1747

6962

DQA10

NOMESCO Finland

Biopsy of larynx

75.5

224.6

261

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

65.0

223.4

265

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.3

221.9

737

1434

TFP20

NOMESCO Finland

Cardiodefibrillation

138.8

221.7

241

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.6

220.6

844

1915

AN1

Coronary angiography

13.4

220.3

403

302

A10BK03

ATC

empagliflozin; oral

707.7

217.3

218

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

5.2

212.9

728

1461

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.4

211.3

1183

3752

ZXE00

NOMESCO Finland

One hour or less

2.4

207.6

2546

13089

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

62.0

206.7

247

UDQ02

NOMESCO Finland

Direct laryngoscopy

36.1

205.6

272

I25.2

ICD-10 Finland

Old myocardial infarction

982.1

202.7

202

I20.99

ICD-10 Finland

Angina pectoris, unspecified

62.3

202.7

242

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

38.7

202.6

264

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

202.5

2817

15359

R33

ICD-10 Finland

Retention of urine

30.6

201.3

277

N05AH04

ATC

quetiapine; oral

4.6

200.7

779

1784

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

200.2

1858

8187

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

25.7

199.0

287

110

N06AX11

ATC

mirtazapine; oral

2.7

197.9

1732

7370

Z3226

NOMESCO Finland

Physiotherapist

3.1

197.3

1258

4369

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

13.3

194.2

356

267

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

15.9

193.1

328

205

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.0

191.2

1324

4851

R49.0

ICD-10 Finland

Dysphonia

13.0

190.7

352

268

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

190.0

2170

10636

XF400

NOMESCO Finland

ECG with 12 standard connections

3.8

183.4

872

2400

ZXA10

NOMESCO Finland

Bilateral

3.2

182.4

1106

3684

N05CF01

ATC

zopiclone; oral

2.5

181.8

1797

8122

104

Kela drug reimbursment

Thyroid insufficiency

4.6

181.7

690

1538

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.5

180.1

974

2976

R23

ICPC

Voice symptom/complaint

10.1

177.9

372

365

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

436.9

177.8

181

N06AB04

ATC

citalopram; systemic

3.1

177.7

1121

3833

C10AA05

ATC

atorvastatin; oral

2.5

177.2

1723

7700

J01DB01

ATC

cefalexin; oral

2.3

176.4

5045

37159

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

117.9

175.8

194

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

175.4

1181

4223

A10BB12

ATC

glimepiride; oral

153.0

175.2

189

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

174.7

1236

4564

N05BA04

ATC

oxazepam; oral

2.8

173.4

1325

5136

E66.01

ICD-10 Finland

Obesity due to excess calories

12.5

172.9

325

257

C10AA01

ATC

simvastatin; oral

2.4

172.9

1914

9139

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

63.7

170.6

203

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

168.7

2252

11750

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

167.8

164

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.0

167.5

1105

3884

I20.09

ICD-10 Finland

Unstable angina

104.5

163.8

183

UJF32

NOMESCO Finland

Coloscopy

2.7

163.3

1377

5640

J01AA02

ATC

doxycycline; systemic

2.2

162.3

4868

35713

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

44.1

161.0

204

A10AE05

ATC

insulin detemir; parenteral

394.4

160.5

164

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

25.8

159.9

230

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

159.8

2416

13255

N06AX16

ATC

venlafaxine; oral

3.9

158.4

717

1878

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.5

157.0

608

1374

B01AF02

ATC

apixaban; oral

9.5

156.9

339

352

N06AX21

ATC

duloxetine; oral

4.4

156.7

619

1427

R03DC03

ATC

montelukast; oral

2.8

156.1

1170

4449

N03AX12

ATC

gabapentin; oral

3.2

155.8

918

2969

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

752.3

155.6

156

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

21.3

154.9

236

108

C01AA05

ATC

digoxin; systemic

16.5

154.7

258

153

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

36.6

154.1

203

H02AB04

ATC

methylprednisolone; systemic

3.0

153.8

1002

3473

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

153.8

3240

20309

R02

ICPC

Shortness of breath/dyspnoea

3.8

153.2

718

1935

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

19.5

152.2

239

120

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.8

152.1

546

1140

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

102.9

152.0

170

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

11.7

151.8

294

247

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

150.3

147

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.4

148.5

483

903

J01FA06

ATC

roxithromycin; oral

2.1

147.8

2512

14352

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

147.3

2707

15964

XF402

NOMESCO Finland

ECG with work load test

4.5

146.7

562

1254

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

146.2

143

C08CA01

ATC

amlodipine; oral

2.3

145.4

1639

7770

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

18.7

144.5

230

120

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

57.8

143.3

173

J01MA12

ATC

levofloxacin; systemic

2.8

142.1

1088

4168

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

142.1

139

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

141.6

1429

6396

R03BA05

ATC

fluticasone; inhalant

2.6

140.9

1237

5131

H02AB07

ATC

prednisone; oral

3.1

138.1

875

2960

ZXD05

NOMESCO Finland

Urgent procedure

2.2

136.7

1732

8639

R53

ICD-10 Finland

Malaise and fatigue

2.7

136.2

1084

4241

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

136.0

133

ZXC10

NOMESCO Finland

Use of laser

8.3

135.5

316

373

C09AA05

ATC

ramipril; oral

2.9

135.2

965

3530

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

5.5

134.9

430

783

Z3231

NOMESCO Finland

Registered nurse

2.3

134.9

1478

6872

R49.09

ICD-10 Finland

Unspecified dysphonia

15.6

134.6

229

143

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

648.6

134.1

135

C07AB02

ATC

metoprolol; systemic

3.0

133.7

878

3039

R42

ICD-10 Finland

Dizziness and giddiness

2.6

132.8

1140

4654

Angiography of the heart and coronary arteries

20.4

131.0

202

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

130.8

128

SPAT1263

SPAT

Sampling

2.0

130.4

2291

13083

R05

ICD-10 Finland

Cough

2.5

129.9

1226

5265

E66.8

ICD-10 Finland

Other obesity

21.9

129.9

196

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

17.3

129.7

212

119

P01BA02

ATC

hydroxychloroquine; oral

5.9

129.1

385

646

WX002

NOMESCO Finland

Sedation and analgesia

2.6

128.4

1089

4406

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

127.7

125

J01FF01

ATC

clindamycin; systemic

2.2

126.9

1575

7734

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

9.6

126.6

271

276

WX892

NOMESCO Finland

Monitored bed care

5.5

126.5

399

717

A02BA02

ATC

ranitidine; systemic

2.6

126.0

1110

4582

R01AD09

ATC

mometasone; nasal

1.9

125.9

2830

17676

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

125.9

2124

11893

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

22.2

125.3

188

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

123.6

121

J01DA01

ATC

[U] cefalexin; systemic

1.9

123.3

3751

26010

XF404

NOMESCO Finland

Ambulatory ECG

4.8

123.0

440

910

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.2

122.6

1626

8209

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

6.7

122.5

331

487

J45.1

ICD-10 Finland

Nonallergic asthma

4.3

122.2

493

1151

RL210

NOMESCO Finland

38.4

122.1

159

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

121.8

2348

13802

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

7.8

121.1

295

373

M79.6

ICD-10 Finland

Pain in limb

2.0

120.8

1984

10949

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

120.7

2655

16370

A02BC04

ATC

rabeprazole; oral

3.5

120.4

616

1770

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

20.6

120.3

185

R03BA08

ATC

ciclesonide; inhalant

3.4

120.2

645

1924

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.9

120.1

419

843

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

13.0

119.7

220

165

N06AB10

ATC

escitalopram; oral

2.6

119.7

990

3933

K78

ICPC

Atrial fibrillation/flutter

12.6

118.0

220

170

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.2

117.5

487

1166

S18

ICPC

Laceration/cut

1.9

116.4

2294

13534

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

115.2

431

933

R03BA02

ATC

budesonide; inhalant

2.4

115.1

1121

4860

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

114.8

1438

7045

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

555.2

114.8

116

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

5.8

114.2

346

591

A10BH05

ATC

linagliptin; oral

550.3

113.7

115

WX734

NOMESCO Finland

JET-ventilation

132.4

113.7

124

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.5

113.0

434

964

C03DA01

ATC

spironolactone; oral

4.3

112.3

453

1056

R03AK07

ATC

formoterol and budesonide; inhalant

2.3

112.2

1225

5618

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

190.5

112.2

119

ZXA05

NOMESCO Finland

Left side

2.2

111.6

1372

6653

I50.0

ICD-10 Finland

Congestive heart failure

13.6

111.5

201

144

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

111.3

2251

13348

M54.5

ICD-10 Finland

Low back pain

2.0

111.3

1799

9798

J04.0

ICD-10 Finland

Acute laryngitis

5.3

110.7

358

661

I20.90

ICD-10 Finland

Angina pectoris, unspecified

222.7

110.4

116

R51.80

ICD-10 Finland

Headache

2.7

110.2

854

3254

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

9.5

110.0

236

241

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

110.0

1511

7685

J01MA02

ATC

ciprofloxacin; systemic

1.9

109.0

2083

12074

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

3.2

109.0

635

2006

205

Kela drug reimbursment

Chronic hypertension

2.4

108.9

1073

4669

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

272.5

108.7

113

WX110

NOMESCO Finland

Local anesthesy

1.8

108.7

4038

29318

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

108.6

1284

6105

L28

ICPC

Limited function/disability (L)

3.0

108.3

713

2452

I25

ICD-10 Finland

Chronic ischaemic heart disease

30.4

107.8

148

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

42.5

107.6

137

J01CA04

ATC

amoxicillin; systemic

1.9

107.6

4911

38197

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.2

106.8

613

1916

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

4.4

105.6

417

951

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.6

104.6

393

853

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.3

103.4

578

1769

Z2446

NOMESCO Finland

Social worker

5.0

103.2

357

710

J01FA10

ATC

azithromycin; systemic

1.8

103.2

3615

25536

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

134.3

102.8

112

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

102.6

1513

7895

A10BD07

ATC

metformin and sitagliptin; systemic

976.0

102.2

102

N06AA09

ATC

amitriptyline; systemic

3.4

102.1

542

1596

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

102.0

806

3096

A10BK01

ATC

dapagliflozin; oral

150.7

102.0

110

T36

ICD-10 Finland

Poisoning by systemic antibiotics

14.1

101.6

180

124

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.6

101.1

374

798

XCK10

NOMESCO Finland

Photography of fundus of eye

4.4

100.6

395

895

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

100.5

789

3020

N06AB03

ATC

fluoxetine; oral

3.1

100.0

603

1945

N05BA01

ATC

diazepam; systemic, rectal

2.9

100.0

661

2272

XG474

NOMESCO Finland

Exhalation nntrogen oxide

6.2

99.0

281

441

N05AH03

ATC

olanzapine; systemic

10.9

98.9

197

175

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

477.0

98.5

100

A28

ICPC

Limited function/disability NOS

3.1

98.1

588

1890

I47.1

ICD-10 Finland

Supraventricular tachycardia

20.7

97.9

150

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

24.7

97.2

141

J45

ICD-10 Finland

Asthma

3.0

97.0

622

2093

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

53.9

96.9

118

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.8

96.5

440

1143

XG410

NOMESCO Finland

Flow-volume spirometry

5.4

96.3

306

552

A06AD11

ATC

lactulose; oral

2.8

95.7

675

2415

UKC02

NOMESCO Finland

Cystoscopy

2.6

95.6

785

3078

B01AB05

ATC

enoxaparin; parenteral

2.0

95.3

1580

8593

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

7.6

95.3

234

299

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

95.1

750

2872

N02AA05

ATC

oxycodone; systemic

2.6

95.0

768

2981

N05CD07

ATC

temazepam; oral

3.2

95.0

560

1778

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

94.5

1946

11452

WX872

NOMESCO Finland

Intensive care

7.3

93.8

236

313

R06AE07

ATC

cetirizine; oral

1.8

93.7

2593

16815

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

35.8

93.3

123

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

93.1

883

3738

R5140

NOMESCO Finland

Monitoring the use of the aid

3.3

93.1

525

1614

R4110

NOMESCO Finland

Physiotherapy

2.0

93.1

1442

7629

C10AX09

ATC

ezetimibe; oral

3.8

93.1

422

1090

I20.00

ICD-10 Finland

Unstable angina

+∞

92.9

SPAT1310

SPAT

Counselling related to known health issue

1.9

92.8

1644

9155

N06AB06

ATC

sertraline; oral

3.4

92.5

481

1390

R03AK08

ATC

formoterol and beclometasone; inhalant

5.0

92.4

315

616

Z2221

NOMESCO Finland

Medical doctor

2.0

92.3

1564

8564

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

92.2

502

1503

M25.5

ICD-10 Finland

Pain in joint

1.9

92.1

1611

8924

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

91.8

1589

8765

R01AD08

ATC

fluticasone; nasal

1.9

91.5

1748

9994

A07AA02

ATC

nystatin; oral

3.9

91.4

408

1039

C10AA07

ATC

rosuvastatin; oral

2.2

91.2

1101

5234

R03BA01

ATC

beclometasone; inhalant

2.4

91.1

855

3597

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.9

91.0

602

2066

A10BJ06

ATC

semaglutide; parenteral

+∞

90.9

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

12.9

90.5

166

124

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

90.4

827

3432

J02AC01

ATC

fluconazole; systemic

1.8

90.0

2475

15956

AN4

Balloon angioplasty and drug eluding stent

+∞

89.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

89.6

666

2458

ZXA00

NOMESCO Finland

Right side

2.0

89.5

1381

7276

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

21.1

89.4

136

SPAT1254

SPAT

Administration of medicine

2.8

89.4

652

2379

T89

ICPC

Diabetes insulin dependent

66.9

89.2

105

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

89.1

2130

13120

L04AX01

ATC

azathioprine; systemic

11.1

88.5

175

153

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

88.1

1289

6644

A07EC02

ATC

mesalazine; oral, rectal

9.8

88.0

185

182

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.7

88.0

656

2423

R03AC13

ATC

formoterol; inhalant

4.3

87.9

350

802

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

7.5

87.8

217

280

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

49.3

87.3

108

B01AC24

ATC

ticagrelor; oral

830.2

86.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.9

86.8

578

1988

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.5

86.1

271

483

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.1

85.7

362

877

J01FA09

ATC

clarithromycin; systemic

1.8

85.6

1925

11589

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

85.2

507

1616

G44.2

ICD-10 Finland

Tension-type headache

2.5

85.1

765

3139

C07AA05

ATC

propranolol; systemic

2.2

84.6

1048

5027

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

145.0

84.2

SPAT1301

SPAT

No procedures

1.9

84.1

1565

8818

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

83.8

1393

7526

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

83.5

772

3215

R03AC03

ATC

terbutaline; inhalant

2.3

83.4

847

3700

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.5

83.1

708

2821

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

40.6

82.7

106

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

6.5

82.4

225

335

R05FB02

ATC

cough suppressants and expectorants

1.8

82.0

2137

13442

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.1

81.6

340

813

R04.2

ICD-10 Finland

Haemoptysis

6.3

81.6

229

354

GBB00

NOMESCO Finland

Tracheostomy

14.8

81.5

141

L03

ICPC

Low back symptom/complaint

2.0

81.3

1251

6553

E66.00

ICD-10 Finland

Metabolic syndrome

8.3

80.9

187

217

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

17.5

80.9

131

R49.03

ICD-10 Finland

Atrophic dysphonia

11.9

80.8

154

125

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

80.5

490

1583

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

6.4

80.3

222

336

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

79.9

932

4342

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

265.4

79.8

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

6.5

79.8

218

325

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.8

79.6

281

570

GD1AD

NOMESCO Finland

Thorax CT examination

4.8

79.4

284

584

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

78.8

1216

6366

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

78.7

582

2134

R01AD12

ATC

fluticasone furoate; nasal

1.8

78.7

1827

11047

UJC01

NOMESCO Finland

Scopy of lower throat

12.6

78.7

146

112

N06AX12

ATC

bupropion; oral

5.6

78.6

242

420

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

78.5

616

2338

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.6

77.9

373

1006

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

44.6

77.9

R07.0

ICD-10 Finland

Pain in throat

3.2

77.9

440

1350

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.5

77.8

292

631

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.9

77.7

346

878

SPAT1153

SPAT

Removal of sutures

1.8

77.6

1694

10029

AN2

Balloon angioplasty, including several vessels

+∞

77.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.4

77.4

302

678

G04CA02

ATC

tamsulosin; oral

2.1

77.1

971

4674

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

9.3

77.0

167

174

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.9

76.9

502

1702

J38.6

ICD-10 Finland

Stenosis of larynx

+∞

76.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

76.3

2015

12655

R50.9

ICD-10 Finland

Fever, unspecified

2.4

76.1

727

3071

I20.01

ICD-10 Finland

Unstable angina

+∞

75.5

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.5

75.5

386

1098

E66.9

ICD-10 Finland

Obesity, unspecified

19.7

75.4

117

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

9.1

75.3

165

175

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

8.9

75.3

167

181

M03BX02

ATC

tizanidine; oral

1.6

75.2

3635

26976

F29

ICD-10 Finland

Unspecified nonorganic psychosis

54.4

74.9

A10AA02

ATC

248.6

74.8

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

74.6

404

1200

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

+∞

74.5

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

74.5

A10BB01

ATC

glibenclamide; oral

74.8

74.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.3

74.2

240

442

L17

ICPC

Foot/toe symptom/complaint

1.9

73.7

1223

6559

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

10.4

73.3

149

138

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

8.2

73.2

171

202

R96

ICPC

Asthma

2.9

73.1

489

1682

N03AE01

ATC

clonazepam; systemic

4.1

73.1

300

707

P01AB01

ATC

metronidazole; oral, rectal

1.7

73.0

2208

14387

N05AX12

ATC

aripiprazole; systemic

23.3

72.7

107

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

35.3

72.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.0

72.5

456

1506

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

72.4

872

4105

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

72.4

661

2723

N03AX09

ATC

lamotrigine; oral

6.1

72.2

207

329

C01BD01

ATC

amiodarone; systemic

87.0

72.2

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

71.9

4061

31215

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

71.8

306

746

J20

ICD-10 Finland

Acute bronchitis

2.7

71.6

537

1982

A07EC01

ATC

sulfasalazine; oral, rectal

3.8

71.4

322

825

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

71.4

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.7

71.3

330

865

M04AA01

ATC

allopurinol; systemic

2.9

71.2

463

1562

A04

ICPC

Weakness/tiredness general

2.5

71.2

601

2373

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

71.1

664

2766

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

70.7

788

3581

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

70.6

446

1477

R55

ICD-10 Finland

Syncope and collapse

2.9

70.5

480

1666

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.0

70.4

297

717

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

20.9

70.4

107

R21

ICPC

Throat symptom/complaint

1.9

70.4

1154

6153

WZC30

NOMESCO Finland

Teaching

2.3

70.2

752

3352

R60.0

ICD-10 Finland

Localized oedema

2.8

70.1

498

1776

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

8.0

70.0

166

201

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

69.9

778

3529

XG466

NOMESCO Finland

Sleep oxymetry

7.3

69.8

175

231

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.9

69.7

459

1560

XQ800

NOMESCO Finland

Prick test

2.7

69.7

512

1865

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

69.5

804

3713

L01

ICPC

Neck symptom/complaint

2.2

69.4

765

3453

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

69.2

352

996

E0000UV

ATC

1.7

69.0

2152

14082

ZY010

NOMESCO Finland

Hospital outpatient

5.7

68.5

208

355

SPAT1229

SPAT

Assessment of need for aid

3.6

68.5

332

904

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

68.4

A10AE06

ATC

insulin degludec; parenteral

+∞

68.4

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

68.1

525

1965

SPAT1097

SPAT

Recording of ECG

2.4

67.8

651

2749

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

67.7

1438

8374

SPAT1216

SPAT

Assessment of functional ability

2.4

67.6

642

2694

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

646.5

67.6

Z71.8

ICD-10 Finland

Other specified counselling

1.9

67.4

1212

6669

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

49.5

67.3

160

Kela drug reimbursment

exenatide

+∞

67.3

M48.0

ICD-10 Finland

Spinal stenosis

2.6

67.1

545

2104

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

66.8

431

1446

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

8.6

66.6

150

167

P76

ICPC

Depressive disorder

4.6

66.5

245

519

UDC00

NOMESCO Finland

Ear microscopy

2.9

66.4

437

1485

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

66.3

959

4859

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

66.1

1256

7038

R03AK11

ATC

formoterol and fluticasone; inhalant

5.3

66.0

212

387

WX722

NOMESCO Finland

PEEP

4.9

65.8

226

445

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

65.7

407

1327

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

65.7

377

1165

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

65.5

3078

22326

J01MA14

ATC

moxifloxacin; systemic

2.6

65.4

506

1898

H26.02

ICD-10 Finland

Presenil cataract

32.3

65.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

65.3

392

1253

R03AC12

ATC

salmeterol; inhalant

4.1

65.1

272

651

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

316.6

65.1

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.5

65.1

548

2157

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

11.7

64.8

124

102

SPAT1260

SPAT

Consultation of another employee

2.1

64.7

848

4122

RP210

NOMESCO Finland

45.5

64.7

M01AH01

ATC

celecoxib; oral (coxibs)

2.0

64.4

954

4875

ZX120

NOMESCO Finland

Intravenous

2.7

64.4

476

1739

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.6

64.3

197

340

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.2

63.9

367

1135

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

63.9

541

2136

A01AB09

ATC

miconazole; local oral

2.6

63.5

489

1829

A10BJ02

ATC

liraglutide; parenteral

85.8

63.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.4

63.3

241

528

R05

ICPC

Cough

1.9

63.1

1167

6465

R07.3

ICD-10 Finland

Other chest pain

2.8

63.1

445

1578

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.3

63.0

339

1001

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.8

62.9

288

747

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

62.9

2144

14282

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

62.8

537

2130

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

28.7

62.8

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

598.3

62.5

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

598.3

62.5

M01AX17

ATC

nimesulide; oral

1.8

62.5

1280

7338

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

5.1

62.4

206

388

F32.1

ICD-10 Finland

Moderate depressive episode

4.7

62.3

223

459

J46

ICD-10 Finland

Status asthmaticus

6.0

62.3

181

293

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

62.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

62.2

2668

18829

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

302.0

62.0

A10AA01

ATC

302.0

62.0

N05CF02

ATC

zolpidem; oral

2.0

61.8

922

4717

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

61.8

385

1260

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

61.7

506

1961

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

15.6

61.7

104

XKD00

NOMESCO Finland

Uroflowmetry

2.2

61.6

705

3230

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

588.7

61.5

WX402

NOMESCO Finland

General anaesthesia

1.9

61.5

969

5064

M01AE02

ATC

naproxen; oral, rectal

1.6

61.1

3247

24093

A10BG03

ATC

pioglitazone; oral

297.2

61.0

K90

ICPC

Stroke/cerebrovascular accident

18.9

60.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

60.6

436

1566

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

6.0

60.5

176

285

N05BA12

ATC

alprazolam; oral

2.6

60.3

475

1798

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

50.4

60.3

C09AA02

ATC

enalapril; systemic

2.1

60.2

765

3666

AN3

Balloon angioplasty and metallic stent

+∞

60.2

A11CC03

ATC

alfacalcidol; systemic

8.3

60.1

138

159

R11

ICD-10 Finland

Nausea and vomiting

3.0

60.1

365

1174

J31.0

ICD-10 Finland

Chronic rhinitis

2.7

59.9

459

1708

UJD02

NOMESCO Finland

Gastroscopy

4.0

59.9

256

625

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

59.6

558

2318

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

59.4

1792

11507

SPAT1325

SPAT

Vaccination

1.7

59.4

1695

10717

H04AA01

ATC

glucagon; nasal, parenteral

91.2

59.4

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.4

59.3

562

2349

F41.1

ICD-10 Finland

Generalized anxiety disorder

6.0

59.3

171

274

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.7

59.1

179

305

K02.1

ICD-10 Finland

Caries of dentine

1.5

59.1

3133

23161

S97

ICPC

Chronic ulcer skin

4.9

59.1

202

396

SPAT1240

SPAT

Therapeutic discussion

2.7

59.0

446

1647

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.2

58.9

340

1054

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

58.7

1444

8745

R06AX27

ATC

desloratadine; oral

1.7

58.6

1590

9904

J45.8

ICD-10 Finland

Mixed asthma

4.8

58.6

204

408

K51.5

ICD-10 Finland

Left sided colitis

79.8

58.5

I48.2

ICD-10 Finland

Chronic atrial fibrillation

559.8

58.4

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

559.8

58.4

A11

ICPC

Chest pain NOS

3.1

58.3

350

1116

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.2

58.2

336

1042

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

41.5

58.2

N05AA02

ATC

levomepromazine; systemic

8.3

58.0

133

153

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

13.9

57.9

102

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

57.8

1280

7501

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

57.7

289

807

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

57.7

1221

7051

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

57.4

607

2676

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

57.3

544

2276

I50.1

ICD-10 Finland

Left ventricular failure

10.7

57.2

114

102

TFP34

NOMESCO Finland

Electrophysiological investigation

18.7

57.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.0

57.2

192

369

P03

ICPC

Feeling depressed

2.9

57.2

370

1242

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

57.1

C09CA01

ATC

losartan; oral

1.9

57.1

1047

5760

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

282.6

57.0

R06.2

ICD-10 Finland

Wheezing

3.8

57.0

258

663

SPAT1058

SPAT

PEF monitoring instruction

2.7

56.7

429

1584

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.4

56.2

536

2246

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.0

56.0

132

159

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.5

55.9

280

782

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

55.8

608

2716

M02AA07

ATC

piroxicam; topical

1.6

55.7

1908

12631

JDB10

NOMESCO Finland

Percutaneous gastrostomy

7.5

55.5

136

174

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

55.5

425

1580

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

55.4

377

1306

C01BC04

ATC

flecainide; systemic

13.8

55.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

55.4

496

2012

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

54.8

423

1581

XF600

NOMESCO Finland

Bloodpressure measurement

3.2

54.2

299

899

N03AG01

ATC

valproic acid; systemic, rectal

4.1

54.0

225

537

F10.09

ICD-10 Finland

Alcohol intoxication UNS

60.9

53.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

53.7

673

3196

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

53.7

1189

6947

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

53.7

405

1494

R31

ICD-10 Finland

Unspecified haematuria

2.6

53.6

418

1572

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.1

53.6

152

239

R03DA04

ATC

theophylline; systemic, rectal

3.4

53.5

279

804

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

53.4

582

2597

SPAT1255

SPAT

Intravenous administration of medicine

3.1

53.1

308

959

I50

ICD-10 Finland

Heart failure

17.6

53.0

A07EA06

ATC

budesonide; oral, local oral

8.7

52.9

118

130

UJC02

NOMESCO Finland

Rigid oesophagoscopy

11.3

52.8

102

N06AX26

ATC

vortioxetine; oral

4.2

52.5

213

496

SPAT1104

SPAT

Monitoring of emergency patient

3.1

52.4

304

947

R04.0

ICD-10 Finland

Epistaxis

3.1

52.2

300

929

H25.0

ICD-10 Finland

Senile incipient cataract

4.5

52.1

195

420

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

52.1

2118

14566

F34.1

ICD-10 Finland

Dysthymia

7.7

52.1

125

155

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

52.0

2234

15565

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

51.9

216

515

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

3.5

51.8

253

692

M05BA04

ATC

alendronic acid; oral

3.0

51.8

316

1019

K30

ICD-10 Finland

Functional dyspepsia

2.3

51.8

515

2200

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.8

51.7

153

254

K50.9

ICD-10 Finland

Crohn disease, unspecified

133.1

51.6

C08CA13

ATC

lercanidipine; oral

2.4

51.6

490

2046

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

15.4

51.5

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

51.5

283

848

M79.7

ICD-10 Finland

Fibromyalgia

5.0

51.3

172

330

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

51.0

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

13.1

51.0

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.2

50.9

291

897

M79.1

ICD-10 Finland

Myalgia

2.1

50.9

642

3053

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

43.5

50.9

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.1

50.8

129

174

R03BB01

ATC

ipratropium bromide; inhalant

4.0

50.8

214

516

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

50.8

269

784

R4120

NOMESCO Finland

Occupational therapy

3.2

50.8

289

888

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

50.5

375

1370

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

26.0

50.1

J34.2

ICD-10 Finland

Deviated nasal septum

3.0

50.0

304

978

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

+∞

50.0

Single vessel balloon catheter extension

+∞

50.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

49.8

571

2603

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.8

49.8

175

354

N07BA03

ATC

varenicline; oral

3.2

49.7

276

834

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

19.3

49.6

D07AC01

ATC

betamethasone; topical

1.6

49.6

1747

11571

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

5.6

49.5

151

260

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

49.5

2873

21332

G04BD12

ATC

mirabegron; oral

2.4

49.5

463

1916

X58

ICD-10 Finland

Exposure to other specified factors

2.0

49.4

743

3792

N07BB01

ATC

disulfiram; oral

5.5

49.3

152

265

177

Kela drug reimbursment

Insulin glargine 300 U / ml

473.2

49.3

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.1

49.1

202

477

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

48.9

K50.8

ICD-10 Finland

Other Crohn disease

+∞

48.9

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

20.7

48.8

N05AF03

ATC

chlorprothixene; systemic

17.1

48.8

J01DA06

ATC

[U] cefuroxime; systemic

1.9

48.7

830

4432

B01AC07

ATC

dipyridamole; systemic

6.7

48.7

129

185

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.1

48.6

160

301

R52.9

ICD-10 Finland

Pain, unspecified

2.5

48.5

408

1598

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

6.4

48.4

132

197

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

48.4

486

2085

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

19.3

48.3

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

7.8

48.1

115

142

R4190

NOMESCO Finland

Nutritional therapy

4.1

48.0

197

464

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.9

48.0

163

318

Coronary artery bypass surgery

+∞

47.9

N05AB03

ATC

perphenazine; systemic, rectal

9.0

47.8

104

110

A12BA01

ATC

potassium chloride; oral

5.7

47.6

143

242

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

12.4

47.5

N06AX03

ATC

mianserin; oral

4.1

47.3

194

457

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

454.0

47.3

C08DB01

ATC

diltiazem; oral

4.5

47.3

177

382

R00.2

ICD-10 Finland

Palpitations

2.7

47.2

355

1305

N05AX08

ATC

risperidone; systemic

3.9

47.1

203

500

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

47.1

218

571

SPAT1312

SPAT

General health counselling

1.6

46.9

1596

10452

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

46.9

R49.1

ICD-10 Finland

Aphonia

22.6

46.8

Z00.0

ICD-10 Finland

General medical examination

1.8

46.6

922

5172

C09CA06

ATC

candesartan; oral

1.8

46.6

1011

5840

A01

ICPC

Pain general/multiple sites

2.7

46.5

340

1229

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

46.4

329

1168

A03FA02

ATC

cisapride; oral, rectal

2.6

46.4

368

1395

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

49.3

46.4

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.7

46.4

332

1185

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.4

46.4

178

394

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

444.4

46.3

S06.0

ICD-10 Finland

Concussion

2.3

46.1

463

1985

M01AB05

ATC

diclofenac; systemic, rectal

1.5

46.0

3772

29890

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

46.0

344

1260

UJC12

NOMESCO Finland

Flexible oesophagoscopy

11.5

46.0

SPAT1053

SPAT

Memory test

2.1

45.9

537

2470

K50.0

ICD-10 Finland

Crohn disease of small intestine

+∞

45.9

Z2445

NOMESCO Finland

Psychologist

5.1

45.8

152

289

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.1

45.7

545

2528

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

45.6

702

3607

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

45.6

523

2383

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

45.5

1441

9253

F41.09

ICD-10 Finland

UNS Panic Syndrome

8.0

45.5

106

126

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

45.3

869

4822

P20

ICPC

Memory disturbance

2.4

45.3

415

1700

I47.2

ICD-10 Finland

Ventricular tachycardia

57.0

45.1

L04AA13

ATC

leflunomide; oral

9.4

45.1

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.7

44.9

210

555

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

14.7

44.9

AA1

Conventional CABG

+∞

44.9

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

151.9

44.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.0

44.7

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

44.7

373

1453

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

15.5

44.7

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

44.6

349

1311

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.0

44.5

277

904

R1260

NOMESCO Finland

Evaluation of communicative skills

8.1

44.5

103

121

Z01.9

ICD-10 Finland

Special examination, unspecified

2.8

44.5

298

1022

R35

ICD-10 Finland

Polyuria

2.9

44.5

292

988

M01AH02

ATC

rofecoxib; oral

2.0

44.4

631

3144

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

44.3

327

1188

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

8.1

44.3

103

122

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

10.6

44.2

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.8

44.1

130

215

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

44.0

550

2599

WZA90

NOMESCO Finland

Other doctors statement

1.7

44.0

1140

6926

ZX114

NOMESCO Finland

Intramuscular

5.7

43.9

131

220

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

15.3

43.9

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

6.6

43.7

117

171

S29

ICPC

Skin symptom/complaint other

1.8

43.6

808

4428

SPAT1211

SPAT

Application of soft bandage

2.3

43.6

423

1783

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

9.9

43.5

C10AA04

ATC

fluvastatin; oral

2.7

43.5

309

1098

N30.0

ICD-10 Finland

Acute cystitis

2.0

43.3

611

3034

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

43.1

340

1283

A46

ICD-10 Finland

Erysipelas

2.1

43.1

517

2401

C07AA07

ATC

sotalol; systemic

6.5

43.0

116

171

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

42.3

3892

31277

R74

ICPC

Upper respiratory infection acute

1.6

42.3

1506

9928

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

53.8

42.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

42.2

301

1073

A02BA04

ATC

nizatidine; systemic

2.5

42.1

356

1395

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.2

42.0

229

683

D01

ICPC

Abdominal pain/cramps general

2.1

41.9

520

2450

F61.0

ICD-10 Finland

Mixed personality disorders

30.1

41.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

41.8

698

3687

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.7

41.8

148

302

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.1

41.8

242

753

K92.1

ICD-10 Finland

Melaena

3.7

41.7

192

501

I48.1

ICD-10 Finland

Persistent atrial fibrillation

109.2

41.7

N03AF01

ATC

carbamazepine; oral, rectal

3.1

41.7

243

757

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

41.7

566

2766

I49.5

ICD-10 Finland

Sick sinus syndrome

7.4

41.7

102

131

C08CA05

ATC

nifedipine; systemic

3.0

41.6

258

842

ZXD20

NOMESCO Finland

Day surgery

1.9

41.5

711

3788

R52.2

ICD-10 Finland

Other chronic pain

4.1

41.5

168

392

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.0

41.4

259

848

R03BC03

ATC

nedocromil; inhalant

2.3

41.3

427

1852

R06AE09

ATC

levocetirizine; oral

1.8

41.3

823

4615

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

396.5

41.2

C01CA24

ATC

epinephrine; parenteral

2.4

41.2

374

1524

WX290

NOMESCO Finland

Other blockade of nerve

1.5

41.0

2325

16961

M01AC06

ATC

meloxicam; systemic, rectal

1.5

41.0

1896

13252

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

41.0

565

2779

L08

ICPC

Shoulder symptom/complaint

1.7

40.9

895

5162

P01

ICPC

Feeling anxious/nervous/tense

2.3

40.9

404

1717

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

139.2

40.8

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

40.8

A10BX07

ATC

[U] liraglutide; parenteral

+∞

40.8

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

40.8

K07

ICPC

Swollen ankles/oedema

4.1

40.7

165

385

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

40.7

816

4581

M10.9

ICD-10 Finland

Gout, unspecified

3.5

40.5

202

563

EBA00

NOMESCO Finland

Extraction of tooth

1.5

40.5

1573

10570

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.9

40.4

104

144

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.9

40.4

258

857

ZY000

NOMESCO Finland

Hospital inpatient

25.8

40.3

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.4

40.1

150

324

B01AF01

ATC

rivaroxaban; oral

2.2

40.1

421

1840

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

40.0

3133

24288

C08CA02

ATC

felodipine; oral

2.6

40.0

318

1206

N06AG02

ATC

moclobemide; oral

3.7

40.0

186

490

A10BH02

ATC

vildagliptin; oral

199.2

39.9

R06.1

ICD-10 Finland

Stridor

18.2

39.9

JN4BD

NOMESCO Finland

Extensive body CT

2.0

39.7

565

2808

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

104.4

39.7

C10AA03

ATC

pravastatin; oral

3.0

39.6

246

804

C03AA03

ATC

hydrochlorothiazide; oral

2.5

39.5

333

1303

R06AX22

ATC

ebastine; oral

1.7

39.5

951

5643

N04BC05

ATC

pramipexole; oral

2.5

39.4

330

1286

C02AC05

ATC

moxonidine; oral

4.3

39.4

151

334

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

8.4

39.4

101

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.4

39.2

148

323

PD5BD

NOMESCO Finland

Extensive CT of aorta

7.3

39.2

127

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.1

39.1

110

172

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

39.1

331

1299

H03BB01

ATC

carbimazole; oral

2.9

39.1

255

858

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

39.0

315

1205

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

38.9

1164

7323

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.3

38.9

125

F10.25

ICD-10 Finland

Alcohol dependence continuous use

42.3

38.9

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.6

38.9

118

203

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.6

38.8

181

478

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

10.8

38.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

38.6

3561

28377

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

38.5

256

872

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

38.4

1463

9761

K76

ICPC

Ischaemic heart dis without angina

23.1

38.4

F10.20

ICD-10 Finland

Alcohol dependence currently independent

28.0

38.3

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.8

38.2

133

267

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.9

38.2

111

181

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

4.9

38.2

130

255

A10BG02

ATC

rosiglitazone; oral

367.7

38.2

P06

ICPC

Sleep disturbance

2.2

38.2

418

1862

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

38.1

192

540

B01AE07

ATC

dabigatran etexilate; oral

5.2

38.0

123

228

L02

ICPC

Back symptom/complaint

2.2

38.0

436

1984

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.0

38.0

237

776

C08DA01

ATC

verapamil; systemic

4.1

38.0

156

369

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

38.0

244

813

K51.8

ICD-10 Finland

Other ulcerative colitis

189.7

37.9

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

37.9

271

967

R95

ICPC

Chron obstructive pulmonary disease

5.1

37.9

123

229

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

37.7

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

37.7

XA800

NOMESCO Finland

Neuropsychological investigation

3.8

37.6

169

433

1420

FHL

Laryngomicroscopy

8.4

37.5

A01AB04

ATC

amphotericin B; local oral

2.9

37.5

247

838

A99

ICPC

Disease/condition unspecnature/site

2.3

37.2

361

1517

Z72.0

ICD-10 Finland

Tobacco use

5.3

37.2

117

210

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

37.2

472

2243

M54.2

ICD-10 Finland

Cervicalgia

2.3

37.1

376

1615

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

37.0

1401

9322

M01AH05

ATC

etoricoxib; oral

1.4

37.0

3270

25764

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.2

36.9

206

626

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

36.8

267

961

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

36.8

342

1409

162

Kela drug reimbursment

liraglutide

+∞

36.7

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

36.7

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

36.7

1335

8798

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

36.6

219

698

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

36.5

211

656

N17

ICPC

Vertigo/dizziness

2.1

36.5

462

2190

N06AA12

ATC

doxepin; systemic

3.3

36.4

195

574

D21

ICPC

Swallowing problem

8.2

36.4

K59.0

ICD-10 Finland

Constipation

2.9

36.3

235

787

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.0

36.3

222

718

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

36.3

271

991

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

15.3

36.3

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

13.5

36.2

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

36.2

292

1117

H36.00

ICD-10 Finland

Diabetic background retinopathy

348.5

36.2

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.9

36.2

156

386

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

180.1

35.9

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

5.1

35.9

117

219

E10

ICD-10 Finland

Type 1 diabetes mellitus

123.3

35.8

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.6

35.8

129

269

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.5

35.8

172

466

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

35.8

172

466

L88

ICPC

Rheumatoid/seropositive arthritis

4.7

35.7

126

257

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

35.7

435

2030

M35.7

ICD-10 Finland

Hypermobility syndrome

18.4

35.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.3

35.7

115

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

26.4

35.6

N05BA02

ATC

chlordiazepoxide; systemic

7.1

35.5

119

UJF92

NOMESCO Finland

Capsular endoscopy

6.9

35.5

126

SPAT1234

SPAT

Support of social functional capacity

3.9

35.4

153

379

N05BE01

ATC

buspirone; oral

5.9

35.4

102

165

-1

NOMESCO Finland

1.5

35.3

1712

12004

R12

ICD-10 Finland

Heartburn

2.3

35.2

330

1365

H26.2

ICD-10 Finland

Complicated cataract

338.9

35.2

TGC00

NOMESCO Finland

Bronchial lavation

4.4

35.2

132

287

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.5

35.1

174

483

WX140

NOMESCO Finland

Parabulbar anesthesy

4.1

35.1

141

327

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

35.1

362

1568

XF640

NOMESCO Finland

5.0

35.1

116

221

D11

ICPC

Diarrhoea

2.0

35.1

491

2424

J01EA01

ATC

trimethoprim; systemic

1.6

35.1

1183

7647

L12

ICPC

Hand/finger symptom/complaint

1.8

34.9

671

3705

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

76.0

34.9

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

120.1

34.8

ENC30

NOMESCO Finland

Plastic operation of pharynx

12.8

34.8

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.3

34.7

181

523

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

34.7

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

34.7

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

11.4

34.6

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.7

34.6

122

249

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

8.9

34.5

106

Kela drug reimbursment

Hypoparathyroidism

16.6

34.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

34.4

233

804

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

34.4

1070

6776

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

34.3

195

599

F32

ICD-10 Finland

Depressive episode

3.3

34.3

182

533

R01AD05

ATC

budesonide; nasal

2.1

34.3

431

2038

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.1

34.2

198

617

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.0

34.2

154

P99

ICPC

Psychological disorders other

7.1

34.1

116

R01AD01

ATC

beclometasone; nasal

1.7

34.1

825

4883

R63.4

ICD-10 Finland

Abnormal weight loss

3.6

34.1

158

416

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.1

34.0

139

328

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.1

34.0

198

620

J96.1

ICD-10 Finland

Chronic respiratory failure

6.7

34.0

127

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

10.6

33.9

R06AX13

ATC

loratadine; oral

1.7

33.9

820

4855

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

5.8

33.8

160

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.4

33.8

135

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.5

33.7

162

439

J05AB01

ATC

aciclovir; systemic

1.6

33.7

1083

6909

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

11.5

33.7

SPAT1059

SPAT

Spirometry at the office

2.8

33.7

233

815

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

33.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

33.6

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

+∞

33.6

R29

ICPC

Respiratory symptom/complaint other

2.4

33.5

308

1262

E000001

ATC

1.6

33.5

1014

6372

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

33.5

186

563

WX704

NOMESCO Finland

Intubation

2.2

33.4

358

1576

K22.1

ICD-10 Finland

Ulcer of oesophagus

7.7

33.2

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.0

33.2

138

331

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

319.7

33.1

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

11.8

33.1

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.8

33.0

J01FA15

ATC

telithromycin; oral

1.9

33.0

548

2881

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

33.0

178

528

K74

ICPC

Ischaemic heart dis with angina

72.2

33.0

T82

ICPC

Obesity

4.4

33.0

125

275

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

32.9

275

1073

XCK00

NOMESCO Finland

Perimetry

2.5

32.9

262

996

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

87.7

32.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.4

32.8

168

479

UGB02

NOMESCO Finland

Tracheoscopy

28.5

32.8

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

17.6

32.8

E03

ICD-10 Finland

Other hypothyroidism

2.3

32.7

310

1289

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

32.6

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.0

32.5

198

638

ACC51

NOMESCO Finland

Release of median nerve

2.2

32.4

342

1498

A12AA04

ATC

calcium carbonate; oral

8.8

32.4

K08.3

ICD-10 Finland

Retained dental root

2.4

32.4

285

1141

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

5.8

32.4

154

U02

ICPC

Urinary frequency/urgency

1.8

32.3

589

3192

F43.1

ICD-10 Finland

Post-traumatic stress disorder

5.3

32.1

101

182

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

38.9

32.1

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

70.3

32.0

N06AB05

ATC

paroxetine; oral

2.6

31.9

237

863

WX320

NOMESCO Finland

Spinalanesthesy

1.6

31.9

1056

6777

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.5

31.9

154

420

K07.60

ICD-10 Finland

Snapping jaw

2.5

31.8

267

1043

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

31.8

166

481

S22.3

ICD-10 Finland

Fracture of rib

2.4

31.7

275

1092

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.7

31.7

144

373

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

4.2

31.7

123

277

H3600, E113

ICD-10 Finland

+∞

31.6

K29.7

ICD-10 Finland

Gastritis, unspecified

3.5

31.6

154

423

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

15.9

31.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

31.5

884

5440

R06.4

ICD-10 Finland

Hyperventilation

5.8

31.5

152

H02AB09

ATC

hydrocortisone; systemic

4.3

31.4

120

266

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

6.3

31.4

131

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.6

31.3

S01BC05

ATC

ketorolac; ophthalmic

4.4

31.3

117

254

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.9

31.3

RD210

NOMESCO Finland

6.1

31.1

136

L13

ICPC

Hip symptom/complaint

1.7

31.1

678

3886

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

5.1

31.0

101

190

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.6

31.0

159

A29

ICPC

General symptom/complaint other

1.9

30.9

472

2405

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

3.8

30.8

136

344

S21

ICPC

Skin texture symptom/complaint

1.8

30.7

570

3106

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.6

30.7

230

844

WW200

NOMESCO Finland

Immunization

3.6

30.6

142

375

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

30.6

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.0

30.4

126

302

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.6

30.4

225

821

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

30.2

2062

15331

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

12.4

30.1

I35.0

ICD-10 Finland

Aortic (valve) stenosis

3.4

30.1

154

439

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

11.5

30.1

A02BX02

ATC

sucralfate; oral

2.9

30.0

191

636

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

104.2

29.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

29.9

182

586

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

11.3

29.8

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

17.8

29.8

130

Kela drug reimbursment

Malignant tumour

1.9

29.8

493

2584

K80

ICPC

Cardiac arrhythmia NOS

2.3

29.8

280

1161

Catheterization and pressure measurement of the left side of the heart

27.8

29.7

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

29.7

2296

17429

L95

ICPC

Osteoporosis

3.7

29.7

133

341

XKC03

NOMESCO Finland

Water cystometry

3.5

29.7

146

404

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.7

29.7

214

769

280

Kela drug reimbursment

Clopidogrel

+∞

29.6

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

29.6

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

29.6

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

29.6

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

+∞

29.6

A06AC51

ATC

ispaghula, combinations; systemic

2.6

29.5

230

864

SPAT1054

SPAT

Examination of peripheral nervous system

16.3

29.4

K77

ICPC

Heart failure

13.3

29.4

J01MA01

ATC

ofloxacin; systemic

2.0

29.4

407

1999

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

8.8

29.4

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

13.8

29.3

DHB50

NOMESCO Finland

Turbinoplasty

3.5

29.3

141

384

TJD20

NOMESCO Finland

Change of gastrostomy tube

12.6

29.2

K84

ICPC

Heart disease other

6.5

29.2

115

M54

ICD-10 Finland

Dorsalgia

1.8

29.2

508

2709

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

29.1

222

824

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

286.3

29.1

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

286.3

29.1

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

286.3

29.1

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

64.3

29.1

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

30.8

29.1

W19

ICD-10 Finland

Unspecified fall

2.0

29.0

376

1797

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

17.5

29.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.8

28.9

138

U04

ICPC

Incontinence urine

3.1

28.9

168

526

DQB70

NOMESCO Finland

Total excision of vocal cord

101.1

28.9

K99

ICPC

Cardiovascular disease other

5.3

28.9

161

N06AX05

ATC

trazodone; oral

5.2

28.9

169

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

14.0

28.9

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.6

28.8

102

210

F31.8

ICD-10 Finland

Other bipolar affective disorders

11.7

28.8

N05AN01

ATC

lithium; oral

9.2

28.7

E66

ICD-10 Finland

Obesity

3.5

28.7

141

390

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

2.1

28.7

362

1713

Z01.2

ICD-10 Finland

Dental examination

1.4

28.6

2139

16116

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

4.7

28.6

199

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

3.7

28.6

130

338

M05BX04

ATC

denosumab; parenteral

2.7

28.6

203

723

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.0

28.6

172

552

XA402

NOMESCO Finland

ENMG

3.3

28.5

147

422

A10BX04

ATC

[U] exenatide; parenteral

+∞

28.5

A10BX02

ATC

repaglinide; oral

+∞

28.5

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

28.5

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

28.5

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.2

28.5

153

453

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

28.5

418

2098

A07EA02

ATC

hydrocortisone; rectal

6.7

28.5

105

M01AB55

ATC

diclofenac, combinations; oral

2.3

28.4

284

1214

WX730

NOMESCO Finland

Conventional respirator

6.9

28.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

10.9

28.3

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.9

28.3

120

294

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

28.3

414

2076

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

28.3

270

1128

P74

ICPC

Anxiety disorder/anxiety state

3.9

28.2

120

295

E83.51

ICD-10 Finland

Hypocalcemia

11.2

28.2

F10.24

ICD-10 Finland

Alcohol depence active use

37.9

28.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

276.4

28.1

SPAT1281

SPAT

Other administrative function

2.1

28.1

316

1424

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.9

28.0

178

591

WX882

NOMESCO Finland

High dependency care

3.9

28.0

119

292

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

28.0

257

1053

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

28.0

544

3008

F60.9

ICD-10 Finland

Personality disorder, unspecified

26.4

28.0

G04CA01

ATC

alfuzosin; oral

1.9

27.9

459

2400

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

12.8

27.9

K91

ICPC

Cerebrovascular disease

15.6

27.8

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.7

27.8

102

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

21.6

27.7

R49

ICD-10 Finland

Voice disturbances

13.3

27.7

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

19.9

27.7

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.7

27.7

123

314

G04BD07

ATC

tolterodine; oral

2.7

27.6

200

718

E21.0

ICD-10 Finland

Primary hyperparathyroidism

5.2

27.6

158

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

3.4

27.6

140

398

C09CA03

ATC

valsartan; oral

2.1

27.5

326

1502

I95.1

ICD-10 Finland

Orthostatic hypotension

4.7

27.5

195

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

27.5

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

27.5

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

27.5

A10BD03

ATC

metformin and rosiglitazone; systemic

+∞

27.5

SPAT1252

SPAT

Overall medication plan or its review

2.5

27.5

218

827

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

27.5

1142

7689

XG405

NOMESCO Finland

Education on PEF monitoring

5.0

27.5

175

EMB10

NOMESCO Finland

Tonsillectomy

2.2

27.4

304

1359

IGY02

NOMESCO Finland

Psychiatric monitoring contact

9.9

27.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.1

27.4

159

498

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

27.3

655

3851

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

27.3

517

2833

J35.0

ICD-10 Finland

Chronic tonsillitis

2.2

27.3

281

1217

GBB13

NOMESCO Finland

Revision of tracheostomy

36.9

27.2

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.2

27.2

278

1200

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.2

27.2

150

454

C07AB03

ATC

atenolol; systemic

2.7

27.1

191

677

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

27.1

157

491

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

266.5

27.1

M01AX05

ATC

glucosamine; oral

1.6

27.1

852

5381

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.5

27.1

224

868

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

27.1

307

1389

K22.2

ICD-10 Finland

Oesophageal obstruction

8.8

27.1

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

27.1

185

643

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.6

27.0

139

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

11.0

26.9

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.8

26.9

116

289

SPAT1081

SPAT

Cardiorespiratory global assessment

2.5

26.9

211

797

V03AA01

ATC

8.0

26.9

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

26.8

142

417

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

26.8

181

626

L86

ICPC

Back syndrome with radiating pain

2.4

26.7

241

979

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

26.7

336

1588

E86

ICD-10 Finland

Volume depletion

6.1

26.7

115

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

44.6

26.7

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.2

26.5

103

233

WX723

NOMESCO Finland

CPAP therapy

3.0

26.5

155

488

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

+∞

26.5

H3601, E103

ICD-10 Finland

+∞

26.5

H3601, E113

ICD-10 Finland

+∞

26.5

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

26.5

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

26.5

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

+∞

26.5

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

26.5

A10BJ05

ATC

dulaglutide; parenteral

+∞

26.5

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

26.5

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

26.5

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.1

26.5

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

26.5

224

881

AP1

Catheterization of the left side of the heart

18.5

26.4

G04BD08

ATC

solifenacin; oral

2.2

26.4

268

1153

C07AG02

ATC

carvedilol; oral

2.7

26.4

182

637

N18.8

ICD-10 Finland

Other chronic renal failure

5.3

26.4

147

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

26.3

189

677

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

10.1

26.3

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.7

26.3

188

M13.9

ICD-10 Finland

Arthritis, unspecified

2.2

26.2

281

1238

U05

ICPC

Urination problems other

2.8

26.2

178

618

J01DC02

ATC

cefuroxime; systemic

2.1

26.2

307

1407

D07XC01

ATC

betamethasone, combinations; topical

1.7

26.2

546

3082

L16

ICPC

Ankle symptom/complaint

1.8

26.1

437

2299

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

26.1

440

2317

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

256.6

26.1

R03DC01

ATC

zafirlukast; oral

4.3

25.9

221

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.4

25.9

129

362

R51

ICD-10 Finland

Headache

2.4

25.9

237

969

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

25.9

436

2297

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.2

25.8

100

226

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

25.8

162

536

Z50.0

ICD-10 Finland

Cardiac rehabilitation

43.3

25.7

JN4AD

NOMESCO Finland

Body CT examination

2.0

25.7

347

1686

TK800

NOMESCO Finland

Hemodialysis

5.8

25.7

121

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.3

25.7

239

987

B01AB04

ATC

dalteparin; parenteral

2.5

25.6

209

806

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

25.6

398

2041

L15

ICPC

Knee symptom/complaint

1.5

25.5

917

5969

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

25.5

191

700

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.4

25.5

137

ZXC60

NOMESCO Finland

Application of heat

5.3

25.5

141

UGC02

NOMESCO Finland

Rigid bronchoscopy

13.9

25.5

SBB10

NOMESCO Finland

Teeth copy

2.1

25.4

311

1453

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

25.4

544

3097

N05AB01

ATC

dixyrazine; systemic

10.1

25.4

GD6AD

NOMESCO Finland

CT of chest and neck

14.6

25.4

X57

ICD-10 Finland

Unspecified privation

3.8

25.4

112

285

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

7.4

25.3

M10.0

ICD-10 Finland

Idiopathic gout

4.0

25.3

103

244

Z01.7

ICD-10 Finland

Laboratory examination

1.8

25.3

502

2791

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

25.3

339

1642

IGY99

NOMESCO Finland

Other psychiatric treatment contact

9.3

25.3

U07

ICPC

Urine symptom/complaint other

2.3

25.2

236

978

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

17.2

25.2

D07AC13

ATC

mometasone; topical

1.4

25.1

1402

9986

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

246.7

25.1

I63.8

ICD-10 Finland

Other cerebral infarction

88.4

25.0

4CJ01

NOMESCO Finland

10.6

25.0

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

24.9

114

299

A04AA01

ATC

ondansetron; systemic, rectal

1.9

24.9

365

1831

J01MA06

ATC

norfloxacin; oral

1.6

24.8

630

3761

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

24.8

264

1161

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

24.8

216

863

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.8

24.6

166

572

C09BA02

ATC

enalapril and diuretics; systemic

2.2

24.6

270

1205

N01

ICPC

Headache

1.8

24.5

436

2339

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

5.1

24.5

148

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

24.5

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

24.5

P15

ICPC

Chronic alcohol abuse

5.8

24.4

114

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4.2

24.4

216

R01AD11

ATC

triamcinolone; nasal

1.8

24.4

452

2459

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.1

24.3

298

1392

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

6.5

24.3

N06AA06

ATC

trimipramine; systemic

4.1

24.3

230

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

19.5

24.3

XJC10

NOMESCO Finland

Oesophageal pH monitoring

18.0

24.3

C10AC01

ATC

colestyramine; oral

3.8

24.2

106

268

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.3

24.2

127

371

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

3.4

24.2

119

331

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.1

24.2

227

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

6.2

24.2

101

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

24.2

146

471

KMAK

NOMESCO Finland

1.3

24.1

2710

21585

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

66.1

24.1

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

236.8

24.1

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

24.1

737

4616

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

24.0

156

527

RS221

NOMESCO Finland

6.2

24.0

102

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.2

24.0

211

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.5

24.0

185

M02AA10

ATC

ketoprofen; topical

1.6

24.0

711

4421

N19

ICD-10 Finland

Unspecified kidney failure

4.1

24.0

220

H01

ICPC

Ear pain/earache

1.7

23.9

483

2697

F41.00

ICD-10 Finland

Moderate panic disorder

20.1

23.9

N06AX22

ATC

agomelatine; oral

6.5

23.9

A10BX01

ATC

guar gum; systemic

4.0

23.8

230

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

23.8

269

1216

-50

ICPC

Medication/prescr/renewal

2.7

23.8

169

602

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.4

23.7

191

R05DA01

ATC

ethylmorphine; oral

1.8

23.7

398

2096

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

12.4

23.7

D07AD01

ATC

clobetasol; topical

1.6

23.7

734

4611

K85

ICPC

Elevated blood pressure

1.7

23.6

585

3466

J96.0

ICD-10 Finland

Acute respiratory failure

8.5

23.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.8

23.6

101

251

N06AB08

ATC

fluvoxamine; oral

3.8

23.5

102

256

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.0

23.5

147

S04

ICPC

Lump/swelling localized

1.8

23.5

427

2309

K04

ICPC

Palpitations/awareness of heart

2.4

23.5

207

831

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

23.5

151

507

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

23.4

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

23.4

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

23.4

XJH00

NOMESCO Finland

Transanal ultrasonography

2.2

23.4

239

1030

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.5

23.4

177

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.1

23.3

221

C05AA08

ATC

fluocortolone; rectal, topical

1.6

23.3

671

4137

NHQ40

NOMESCO Finland

Amputation of toe

10.4

23.3

S80.0

ICD-10 Finland

Contusion of knee

2.0

23.3

292

1378

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

4.1

23.2

218

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

23.2

132

408

I95.9

ICD-10 Finland

Hypotension, unspecified

7.8

23.2

F32.8

ICD-10 Finland

Other depressive episodes

9.1

23.1

F60.5

ICD-10 Finland

Anankastic personality disorder

10.7

23.1

L04AA06

ATC

mycophenolic acid; systemic

6.1

23.1

100

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

227.0

23.1

AA5PD

NOMESCO Finland

CT examination of brain pefusion

21.5

23.1

I42.0

ICD-10 Finland

Dilated cardiomyopathy

5.0

23.1

146

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

16.7

23.1

K92.0

ICD-10 Finland

Haematemesis

4.4

23.1

188

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

82.1

23.1

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

82.1

23.1

R28

ICPC

Limited function/disability (R)

5.9

23.0

104

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

23.0

184

703

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

5.5

23.0

119

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

118.3

23.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.4

23.0

114

320

Z43.0

ICD-10 Finland

Attention to tracheostomy

39.2

22.9

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

7.9

22.9

L29

ICPC

Musculoskeletal sympt/complt other

2.0

22.9

311

1516

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

10.4

22.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.1

22.8

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.9

22.8

375

1958

N18

ICPC

Paralysis/weakness

6.4

22.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

22.8

168

613

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.9

22.7

231

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

22.7

121

358

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

7.5

22.7

WF002

NOMESCO Finland

Radical radiotherapy

2.1

22.7

275

1280

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

22.5

238

1043

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.3

22.5

117

340

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

7.4

22.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.0

22.5

100

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

22.5

299

1445

E66.0

ICD-10 Finland

Obesity due to excess calories

51.1

22.4

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

22.4

A10BJ01

ATC

exenatide; parenteral

+∞

22.4

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

22.4

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.6

22.4

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.0

22.4

135

435

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

22.4

970

6558

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

22.3

125

384

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

22.3

852

5613

M01AB01

ATC

indometacin; systemic, rectal

2.0

22.3

289

1384

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

217.6

22.1

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

78.9

22.1

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

13.9

22.1

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

9.7

22.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.6

22.0

158

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

11.1

22.0

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

11.1

22.0

F22.0

ICD-10 Finland

Delusional disorder

37.8

22.0

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

5281

33195

2.82

321.28

5.0

2.6

mm/h

11.8

9.8

21.15

4882

30601

(3019309) Folate [Moles/volume] in Red Blood Cells

1433

4694

3.29

310.23

1.8

1.5

nmol/l

1164.6

1121.9

0.91

1060

3477

(3018418) pH of Serum or Plasma

2373

10299

2.71

308.58

5.3

3.4

7.4

0.01

504

1795

(3013115) Eosinophils [#/volume] in Blood

4048

20550

2.91

307.65

6.4

4.2

e9/l

0.2

0.62

3632

17772

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3943

17807

3.35

307.65

9.1

4.9

mmol/l

1.2

21.28

3338

15052

(42870588) Differential panel, method unspecified - Blood

2896

12209

3.02

307.65

6.2

4.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

3799

19672

2.69

307.65

6.5

4.2

27.3

29.8

35.09

3534

18259

(3019198) Lymphocytes [#/volume] in Blood

3990

20452

2.83

307.65

6.3

4.1

e9/l

1.9

2.0

2.53

3597

17789

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3722

16000

3.42

307.65

8.1

4.3

mmol/l

1.2

20.21

3381

14334

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1941

7105

3.11

307.65

2.4

1.7

mg/l

2.9

2.6

4.77

1646

5935

(3001604) Monocytes [#/volume] in Blood

3900

19609

2.86

307.65

6.2

4.1

e9/l

0.6

0.5

13.35

3467

16682

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2184

6788

3.86

307.65

3.3

1.8

ng/l

1168.3

436.8

13.92

1856

5561

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1437

4491

3.47

307.65

2.1

1.6

—

(3023368) Bacteria identified in Blood by Culture

2156

8148

3.09

307.65

4.9

3.5

—

(3032080) INR in Blood by Coagulation assay

3134

12403

3.40

307.65

8.9

3.6

inr

1.2

1.1

9.93

889

3391

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1203

3309

3.86

307.65

6.1

4.7

mmol/l

1.0

1.89

1110

3078

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3922

20313

2.75

307.65

7.0

6.3

umol/l

10.9

11.2

0.71

3697

19345

(3009508) Creatinine [Moles/volume] in Urine

1958

6989

3.21

307.65

3.2

2.0

mmol/l

7.5

8.2

9.23

1626

5952

(3018010) Neutrophils/100 leukocytes in Blood

3732

19351

2.65

307.65

6.3

4.1

57.8

55.6

25.32

3493

18063

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5410

33209

3.10

307.65

9.2

5.9

u/l

76.6

77.0

0.21

5117

31033

(3020682) Albumin/Creatinine [Ratio] in Urine

1856

6466

3.25

307.65

4.0

2.2

mg/mmol

8.9

7.7

0.43

1162

3282

(3019069) Monocytes/100 leukocytes in Blood

3708

18856

2.71

307.65

6.7

4.4

8.5

8.4

1.51

3475

17586

(3006504) Eosinophils/100 leukocytes in Blood

3691

18721

2.72

307.65

6.4

4.2

2.8

2.9

1.86

3453

17315

(3013650) Neutrophils [#/volume] in Blood by Automated count

4374

24078

2.77

307.65

9.7

7.5

e9/l

4.2

3.8

24.49

3893

20645

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1582

4693

3.74

307.65

4.1

3.6

mmol/l

0.8

7.43

1479

4381

(3013826) Glucose [Moles/volume] in Serum or Plasma

4283

21377

3.14

307.65

6.2

3.1

mmol/l

6.5

6.1

38.34

4074

19629

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2897

13353

2.71

307.65

2.1

1.5

pmol/l

96.4

99.7

2.83

1555

6400

(3022096) Basophils/100 leukocytes in Blood

3591

18004

2.71

307.65

6.4

4.2

0.7

1.88

3348

16683

(3006315) Basophils [#/volume] in Blood

3910

19681

2.86

307.65

6.3

4.1

e9/l

0.0

4.27

3477

16715

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2356

9080

3.10

307.65

2.4

1.7

u/l

200.7

185.6

0.34

2223

8466

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2882

12118

3.02

307.65

4.1

1.9

ng/l

39.7

23.2

2.03

1914

6358

(3024561) Albumin [Mass/volume] in Serum or Plasma

3341

15142

2.97

307.65

5.2

4.1

g/l

35.5

36.3

14.19

3076

14012

(3012516) Albumin [Mass/volume] in Urine

1793

6159

3.27

307.65

3.3

2.0

mg/l

261.9

795.7

4.24

1127

3075

(40768797) Stomach Pathology biopsy report

1359

4413

3.30

297.46

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3126

16053

2.44

279.14

2.5

1.8

nmol/l

79.7

78.4

1.61

2824

14520

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1009

2824

3.70

277.04

9.7

5.6

kpa

5.2

5.1

1.13

949

2709

(3027801) Oxygen [Partial pressure] in Arterial blood

1008

2823

3.70

276.48

9.6

5.6

kpa

12.0

14.4

32.23

948

2707

(3015377) Calcium [Moles/volume] in Serum or Plasma

2748

13361

2.48

276.17

3.7

3.8

mmol/l

2.3

2.4

8.77

2374

11838

(3003396) Base excess in Arterial blood by calculation

1002

2843

3.64

269.21

9.7

5.5

mmol/l

1.4

0.8

6.36

811

2263

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2448

11418

2.51

267.49

2.8

2.2

u/l

55.7

61.9

3.84

2222

10558

(3022217) INR in Platelet poor plasma by Coagulation assay

1003

2941

3.52

255.73

27.2

7.8

inr

1.4

1.1

5.58

143

517

(3031040) Bacteria [#/volume] in Urine by Automated count

4648

29085

2.38

255.13

5.2

3.1

e6/l

908.5

1222.6

0.19

367

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5408

36228

2.58

254.66

5.7

3.5

pmol/l

15.1

14.5

50.28

4963

33140

(3016502) Oxygen saturation in Arterial blood

892

2438

3.74

252.55

10.3

5.9

95.8

96.8

5.53

853

2345

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

887

2434

3.72

249.55

4.6

3.6

pmol/l

4.5

4.6

1.00

805

2196

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1249

4256

3.09

248.86

2.5

1.9

30.0

28.9

7.40

1207

4147

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1489

5599

2.86

248.54

4.4

2.2

ng/l

383.7

259.6

0.69

1115

3628

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

985

2926

3.47

245.65

2.0

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

906

2591

3.57

239.24

2.4

2.7

nmol/l

352.7

386.5

4.38

828

2425

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

674

1571

4.29

237.26

2.5

1.5

ug/l

7.9

5.3

1.62

571

1362

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

975

2944

3.40

236.56

2.0

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4718

30322

2.31

233.32

5.0

3.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

784

2098

3.77

228.00

7.1

5.4

mmol/l

8.9

7.7

5.13

747

2015

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

777

2073

3.78

226.92

4.0

3.1

ng/l

76.3

71.2

0.83

671

1838

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

292

311

9.05

226.00

8.5

7.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1065

3513

3.13

222.78

2.7

1.9

22.4

26.4

12.82

905

3037

(3022948) Iron [Moles/volume] in Serum or Plasma

1217

4348

2.93

221.11

2.6

1.8

umol/l

13.2

15.2

14.51

1114

4045

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

638

1503

4.23

221.07

4.5

3.0

kpa

5.2

5.1

2.33

599

1404

(3009343) pH of Capillary blood

629

1487

4.21

216.84

4.6

3.0

7.4

0.35

169

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1126

3903

2.99

215.65

2.6

1.8

g/l

2.4

0.07

1031

3626

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

614

1440

4.24

213.83

4.5

3.0

mmol/l

1.7

1.5

0.42

481

1068

(3021960) Folate [Moles/volume] in Serum or Plasma

1669

7141

2.53

212.01

1.6

1.3

nmol/l

20.1

21.2

1.73

1433

5981

(3014111) Lactate [Moles/volume] in Serum or Plasma

775

2163

3.61

211.28

9.5

5.7

mmol/l

1.3

1.2

1.91

746

2089

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6083

44675

2.76

208.56

6.7

3.8

mu/l

2.3

2.2

0.09

5635

40986

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3197

18128

2.15

207.79

3.3

2.3

ug/l

120.4

112.1

0.75

2963

17080

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1871

8535

2.40

205.91

2.0

1.5

mg/l

1.1

0.01

1416

6467

(3002173) Hemoglobin [Mass/volume] in Arterial blood

808

2362

3.45

204.99

10.8

6.1

g/l

121.6

122.2

0.35

770

2261

(3013512) EKG study

2176

10707

2.28

199.99

4.3

2.4

—

(3000991) Gas panel - Venous blood

735

2058

3.58

198.99

10.6

6.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6498

49779

3.30

198.31

19.8

7.9

mg/l

22.2

24.2

5.20

5459

35330

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

33.36

198.23

3.1

2.1

nmol/l

0.8

0.9

0.16

104

(3021447) Carbon dioxide [Partial pressure] in Venous blood

720

2011

3.59

195.55

4.2

3.4

kpa

6.0

5.8

2.16

696

1957

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

323

461

6.77

195.08

8.1

5.3

u/ml

83.1

135.4

0.75

128

147

(3012544) pH of Venous blood

733

2087

3.52

193.28

4.3

3.4

7.4

—

(3002032) Base excess in Venous blood by calculation

712

2003

3.56

191.14

4.2

3.4

mmol/l

2.2

1.9

1.02

585

1633

(3019060) Gas panel - Arterial blood

583

1433

4.02

190.11

6.0

3.7

—

(3044640) Blood type and Crossmatch panel - Blood

2545

13577

2.15

189.27

2.8

2.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

964

3296

2.98

187.66

9.8

6.0

mmol/l

104.3

104.8

2.35

949

3224

(3007853) Bacteria identified in Skin by Aerobe culture

1071

3912

2.81

184.54

2.0

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

753

2257

3.35

182.85

2.9

2.4

g/l

10.3

10.4

0.27

685

2061

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3519

21403

2.04

181.82

4.3

3.4

—

(3026008) Bacteria identified in Urine by Culture

2106

10612

2.19

179.25

3.4

2.2

—

(3002582) Erythrocytes [#/volume] in Urine

2204

11347

2.16

177.33

3.6

2.5

e6/l

70.0

81.5

0.13

1713

8228

(3000850) Epithelial cells [#/volume] in Urine

1611

7294

2.36

176.94

2.8

2.0

e6/l

4.7

5.9

3.19

1396

6271

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

625

1697

3.65

176.54

1.7

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1208

4796

2.61

176.20

1.4

1.3

titre

554.6

411.5

1.44

239

811

(3018095) Leukocytes [#/volume] in Urine

2535

13831

2.09

174.65

4.2

2.8

e6/l

60.7

74.3

0.81

1835

9106

(3007164) IgA [Mass/volume] in Serum or Plasma

1666

7710

2.31

173.52

1.6

1.3

g/l

2.3

2.2

0.73

1027

4809

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

619

1700

3.61

171.78

3.2

1.7

ng/l

164.2

88.6

6.17

566

1506

(3030467) Casts [#/volume] in Urine by Automated count

2040

10314

2.17

170.81

3.5

2.4

e6/l

0.3

0.4

2.13

1546

7295

(3042936) Bacteria identified in Isolate by Culture

1184

4745

2.58

168.87

2.1

1.6

—

(36304419) Bacteria [Presence] in Urine

2013

10206

2.16

166.69

3.4

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2001

10158

2.15

164.87

2.7

2.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2343

12639

2.07

164.36

3.5

2.9

u/l

31.7

31.9

0.05

2214

12115

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1452

6489

2.35

162.84

1.7

1.4

pmol/l

4957698.6

37514136.9

3.53

1170

5478

(3026782) Osmolality of Urine

1496

6799

2.32

161.20

2.8

2.1

mosm/kgh2o

530.8

572.3

10.72

1264

5728

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

327

577

5.47

159.33

3.1

2.5

u/ml

0.3

0.68

183

283

(3027945) Reticulocytes/100 erythrocytes in Blood

841

2914

2.90

158.52

2.7

1.8

1.6

4.84

729

2623

(3033658) Prothrombin time (PT) actual/Normal

1970

10101

2.12

156.93

4.7

3.1

90.9

95.9

15.45

1926

9868

(3022313) Gas panel - Capillary blood

464

1117

4.06

155.05

4.8

3.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1812

9066

2.15

153.30

1.3

1.2

u/ml

1.7

2.1

0.35

461

2580

(3005322) IgE [Units/volume] in Serum or Plasma

787

2676

2.95

153.27

1.5

1.2

u/ml

131.6

204.0

3.79

748

2484

(3024354) Oxygen [Partial pressure] in Venous blood

580

1642

3.48

153.25

3.5

3.0

kpa

4.8

4.6

1.08

559

1593

(3019550) Sodium [Moles/volume] in Serum or Plasma

6488

51261

2.87

153.21

21.5

8.4

mmol/l

139.6

139.9

22.60

6350

49550

(3048689) Calprotectin [Mass/mass] in Stool

1063

4228

2.57

152.94

2.2

1.2

ug/g

127.8

82.3

3.08

843

3133

(3009445) Proteinase 3 Ab [Units/volume] in Serum

449

1069

4.10

152.26

1.6

1.1

u/ml

20.5

1.2

0.88

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1469

6784

2.27

151.41

3.2

3.3

mmol/l

2.4

0.35

1271

6037

(3023103) Potassium [Moles/volume] in Serum or Plasma

6498

51501

2.86

149.98

21.7

8.5

mmol/l

3.9

1.15

6349

49655

(3028026) IgM [Mass/volume] in Serum or Plasma

580

1703

3.35

144.53

2.1

1.9

g/l

1.3

1.5

1.15

532

1559

(3008152) Bicarbonate [Moles/volume] in Arterial blood

528

1460

3.55

144.43

8.9

5.0

mmol/l

25.1

24.7

1.65

480

1345

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

403

920

4.25

144.39

2.9

2.4

—

(3021589) Normoblasts [#/volume] in Blood

3073

18869

1.90

143.33

11.1

6.5

e9/l

0.0

0.71

2558

15107

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

500

1340

3.65

143.31

12.4

7.2

mmol/l

24.8

24.3

3.44

464

1277

(3019225) pH of Specimen

933

3602

2.62

142.06

5.1

3.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

532

1496

3.49

141.78

1.8

1.5

—

(40758558) Short blood count panel - Blood

1956

10389

2.03

138.95

7.4

6.3

—

(3023419) Bacteria identified in Sputum by Culture

217

299

6.92

135.12

3.1

2.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

820

3040

2.70

135.03

2.4

2.2

g/l

0.2

1.80

774

2888

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

412

1035

3.86

129.44

5.1

3.3

mmol/l

24.9

0.01

382

978

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

329

698

4.54

129.25

2.4

1.9

ug/l

753.2

365.8

0.39

312

647

(3044889) 12 lead EKG panel

4495

31747

1.85

128.39

4.4

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

663

2254

2.91

128.32

2.6

3.1

g/l

66.3

67.1

1.94

596

2100

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

906

3622

2.51

127.58

3.8

5.2

u/l

239.7

245.5

0.43

854

3472

(4010399)

744

2712

2.73

126.26

1.5

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

623

2073

2.96

125.24

2.6

2.8

e9/l

68.7

66.5

0.75

472

1505

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

148

140

10.00

124.66

2.5

2.4

ug/min

100.6

98.1

0.02

(3035350) Ketones [Presence] in Urine by Test strip

3250

20956

1.81

123.88

3.9

2.6

estimate

0.0

0.80

656

3380

(3021601) Nitrite [Presence] in Urine by Test strip

3273

21254

1.79

120.85

5.2

3.6

estimate

0.0

0.37

680

3482

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4492

32036

1.81

120.44

3.6

2.3

u/l

50.4

38.2

8.16

4172

30155

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5678

43632

2.01

120.25

6.1

3.0

mmol/mol

39.4

36.4

121.00

5244

40210

(3004119) Hemoglobin [Mass/volume] in Venous blood

445

1239

3.49

120.04

3.7

2.8

g/l

126.9

131.0

2.80

426

1211

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

352

834

4.07

119.79

1.5

1.4

titre

153.3

205.2

0.25

(3009261) Glucose [Presence] in Urine by Test strip

3288

21419

1.79

119.74

4.0

2.6

estimate

0.0

0.00

665

3527

(40768804) Tissue Pathology biopsy report

3279

21392

1.78

118.36

2.3

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

410

1093

3.63

118.07

4.2

4.3

mmol/l

24.4

24.3

0.18

367

1004

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

486

1448

3.27

117.76

12.3

6.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1824

9999

1.93

114.80

2.7

2.2

umol/l

1627.3

4841.2

5.57

1567

8873

(3004588) Protein electrophoresis panel - Serum or Plasma

529

1698

3.04

113.00

2.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

360

916

3.79

110.86

3.1

2.7

1.5

1.1

6.67

360

908

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

320

750

4.10

110.42

1.7

1.2

g/l

0.2

2.13

297

709

(3000494) Fungus identified in Specimen by Culture

1055

4805

2.22

109.31

1.6

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

354

907

3.76

107.91

3.2

2.7

0.6

0.7

0.29

340

858

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

827

3421

2.41

107.17

3.7

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

325

789

3.96

106.87

1.7

1.2

g/l

1.2

0.86

303

750

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1399

7224

1.99

103.47

1.4

1.2

iu/ml

27.0

22.7

0.48

413

2130

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

343

892

3.70

102.27

2.4

1.8

ug/l

1.5

2.0

0.54

299

797

(3015235) Bicarbonate [Moles/volume] in Capillary blood

245

499

4.69

101.03

3.3

2.3

mmol/l

25.1

24.7

0.75

217

440

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

285

666

4.10

98.66

1.5

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5962

47573

1.98

98.60

17.0

7.7

ml/min/173m2

83.0

83.9

2.90

5102

37575

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

950

4321

2.20

98.04

2.5

2.6

umol/l

7.7

8.1

0.16

804

3799

(3017181) Myelocytes/100 leukocytes in Blood

656

2544

2.54

97.33

3.7

3.4

0.8

1.0

1.18

193

679

(3042631) Mycobacterium sp identified in Specimen

201

357

5.35

97.01

3.0

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1314

6784

1.98

96.53

1.3

1.2

u/ml

15.1

2.9

2.27

469

2714

(3020891) Body temperature

323

845

3.67

95.42

6.6

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1242

6321

2.00

94.90

3.1

2.2

e6/l

0.8

1.0

1.45

700

3339

(3022145) Colonoscopy Study observation

924

4217

2.19

94.34

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1645

9213

1.85

94.16

4.7

3.0

—

(3000492) Spirometry study

949

4383

2.17

94.01

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

305

780

3.75

93.11

1.3

ug/g

300.4

278.8

0.95

177

439

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

287

705

3.90

92.76

1.4

1.1

iu/ml

11.0

7.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

625

2434

2.52

91.73

3.8

3.4

0.2

0.27

182

630

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

472

1601

2.86

90.94

1.6

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

340

964

3.39

88.83

3.9

2.3

mmol/l

25.7

25.6

0.40

331

938

(40761511) CBC panel - Blood by Automated count

6524

54295

2.31

88.82

17.9

7.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

286

723

3.79

88.74

6.1

2.9

mmol/l

1.2

0.45

281

715

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

652

2650

2.41

87.11

4.7

2.9

mmol/l

1.2

8.24

576

2286

(3021901) Oxygen saturation in Capillary blood

185

336

5.22

87.10

3.0

2.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

339

975

3.34

86.57

1.8

1.6

g/l

1.7

1.4

4.10

290

817

(3002179) Metamyelocytes/100 leukocytes in Blood

590

2302

2.50

86.09

3.6

3.4

0.7

0.8

0.31

144

483

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1171

6029

1.96

85.76

3.3

2.3

e6/l

3.0

2.6

0.69

628

3057

(3025159) Blasts/100 leukocytes in Blood

588

2298

2.50

85.48

3.9

3.4

0.0

0.5

1.34

156

539

(3028626) Oxygen [Partial pressure] in Capillary blood

240

553

4.14

84.60

4.7

3.6

kpa

8.4

8.9

4.38

225

516

(1616796) Gas panel - Central venous blood

218

471

4.40

83.53

4.8

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1636

9467

1.78

82.58

1.7

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

216

468

4.39

82.47

1.7

1.3

g/l

0.6

0.8

1.37

153

352

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6011

48867

1.89

82.28

4.9

3.2

mmol/l

5.9

5.5

98.18

5488

44939

(4146454)

11.13

81.79

2.8

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

196

397

4.69

81.33

1.2

1.1

—

(4062490)

166

292

5.38

80.95

1.7

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6579

55317

2.29

80.53

12.8

6.8

u/l

26.1

24.8

3.08

6376

53143

(3028192) IgG subclass 2 [Mass/volume] in Serum

165

295

5.29

79.05

1.7

1.2

g/l

2.7

3.1

1.75

109

201

(3024139) IgG subclass 3 [Mass/volume] in Serum

165

296

5.28

78.75

1.7

1.2

g/l

0.3

0.4

2.13

110

198

(3027135) IgG subclass 1 [Mass/volume] in Serum

165

297

5.26

78.46

1.7

1.2

g/l

6.5

6.8

0.28

109

201

(3024928) Oxygen saturation in Venous blood

187

378

4.69

77.78

3.5

4.2

—

(3010421) pH of Blood

239

585

3.89

77.57

4.9

2.6

7.4

0.04

205

492

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

417

1447

2.78

76.78

1.9

2.0

u/l

38.3

41.3

2.39

369

1333

(40767503) Oxygen content in Capillary blood by calculation

210

471

4.24

76.68

2.9

1.9

16.7

17.2

0.78

114

231

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

254

660

3.67

75.69

1.8

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1776

10755

1.71

75.30

4.5

2.7

estimate

0.0

0.13

663

3415

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

156

277

5.32

75.30

1.5

1.2

u/ml

0.6

1.5

0.58

110

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

390

1320

2.84

75.22

2.0

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

750

3469

2.13

73.02

2.7

2.2

u/l

37.6

45.7

0.58

631

3027

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

460

4.17

72.30

1.6

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

252

673

3.57

72.09

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1557

9228

1.72

70.76

3.8

2.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

290

864

3.21

69.85

1.8

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

175

367

4.51

69.60

2.9

2.6

umol/l

34.8

35.5

0.11

152

320

(3030905) Polymorphonuclear cells [#/volume] in Blood

209

507

3.91

68.68

3.0

2.7

e9/l

3.8

0.01

209

507

(3012501) Base excess in Blood by calculation

207

501

3.92

68.24

5.3

2.7

mmol/l

3.1

2.4

2.78

154

328

(3006184) Hemoglobin [Mass/volume] in Capillary blood

233

614

3.61

67.99

2.4

1.8

g/l

132.7

133.2

0.11

157

420

(3015171) Extractable nuclear Ab [Units/volume] in Serum

359

1233

2.79

67.29

1.2

u/ml

3.6

0.5

1.03

110

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

214

539

3.77

66.70

3.2

2.9

56.4

55.5

0.41

214

539

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

1192

2.82

66.64

2.0

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

860

4322

1.96

66.36

1.8

1.4

1.5

1.2

15.25

741

3931

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

289

889

3.10

65.96

1.7

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

235

639

3.50

65.41

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

356

1238

2.76

65.15

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

235

641

3.49

65.10

6.8

3.0

mmol/l

3.8

0.20

225

600

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

220

575

3.63

64.98

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

220

575

3.63

64.98

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

508

2102

2.34

64.64

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

123

203

5.71

64.20

2.5

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

238

666

3.40

63.37

1.5

iu/ml

0.6

3.2

0.54

150

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2448

16616

1.56

63.20

4.2

2.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

204

520

3.72

62.49

2.8

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

147

6.59

62.05

2.0

1.6

nmol/l

0.9

0.8

0.55

139

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

169

378

4.23

61.94

1.7

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

147

295

4.70

61.69

6.2

5.5

mg/l

11.1

11.4

0.28

135

281

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

152

314

4.57

61.59

1.7

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

293

957

2.92

60.20

2.7

2.4

g/l

3.8

3.5

1.46

284

908

(3036489) Thrombin time

341

1208

2.70

60.18

2.2

1.9

21.9

21.0

1.43

299

1031

(3052851) Hemolysis interference index of Serum or Plasma

281

900

2.98

59.78

3.5

2.6

—

(3017732) Neutrophils [#/volume] in Blood

615

2849

2.10

59.15

2.8

2.1

e9/l

4.3

3.8

2.41

471

2357

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1007

5540

1.80

58.13

4.6

3.6

32.9

32.0

1.74

723

3530

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

162

369

4.15

57.98

1.3

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

278

903

2.93

57.67

1.3

1.2

u/ml

17.6

24.6

0.24

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

156

347

4.25

57.60

1.8

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

188

480

3.71

57.46

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

301

1027

2.80

57.06

6.0

3.9

1.7

1.6

0.79

269

958

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

904

4867

1.83

55.88

7.9

3.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

829

4355

1.87

55.40

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

354

4.13

55.29

1.6

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

265

859

2.94

55.17

2.1

mg/l

11.1

10.3

1.16

244

817

(3019230) Fractional oxyhemoglobin in Venous blood

154

355

4.10

54.26

3.4

3.8

64.3

62.6

0.37

154

355

(3003181) Sodium [Moles/volume] in Urine

149

335

4.20

54.26

1.4

1.3

mmol/l

65.3

72.2

0.88

120

268

(36660697) Celiac disease serology panel - Serum

662

3252

1.98

54.03

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

291

1011

2.74

53.29

6.1

3.8

0.9

0.13

260

941

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

251

808

2.95

52.91

1.3

1.2

u/ml

9.1

4.4

0.30

(3047181) Lactate [Moles/volume] in Blood

263

871

2.87

52.67

6.6

4.0

mmol/l

1.2

0.93

223

769

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

207

598

3.28

52.40

1.2

u/ml

9.6

5.8

0.15

(3020191) Ethanol [Moles/volume] in Serum or Plasma

107

7.10

52.38

1.4

1.1

promille

1.5

1.1

1.15

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

638

3131

1.98

52.15

2.5

2.4

au/ml

21.9

25.7

0.23

282

(3019150) Specific gravity of Urine by Refractometry

1396

8628

1.62

51.96

4.2

2.7

kg/l

1.0

0.38

192

1323

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

593

2848

2.02

51.50

1.4

1.3

au/ml

40.9

49.3

0.33

156

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

246

795

2.94

51.49

1.2

u/ml

2.8

2.4

0.14

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

1028

2.69

51.07

2.5

2.4

g/l

7.4

7.0

2.31

213

827

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

262

881

2.83

51.02

2.7

2.5

g/l

1.2

1.0

0.22

219

779

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

1027

2.68

50.64

2.5

2.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4398

34618

1.47

50.64

3.5

2.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

287

1025

2.67

49.80

2.5

2.4

g/l

3.8

0.22

205

773

(46235355) HIV 1 and 2 tests - Meaningful Use set

1316

8092

1.63

49.76

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

138

6.05

49.53

1.2

1.1

iu/ml

52.5

19.2

0.47

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

988

2.69

49.22

2.6

2.5

g/l

3.0

2.9

0.53

208

808

(3003327) Ova and parasites identified in Stool by Light microscopy

342

1341

2.44

48.89

1.9

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

225

712

3.00

48.88

3.7

4.2

mg/l

62.5

42.0

0.32

171

611

(40761535) Cells panel - Urine sediment

565

2717

2.01

48.82

3.6

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

220

689

3.03

48.67

3.7

4.2

ratio

3.2

5.1

0.24

(3034860) Kappa light chains.free [Mass/volume] in Serum

224

712

2.98

48.29

3.7

4.2

mg/l

46.0

44.0

0.14

170

606

(40761536) Microorganisms panel - Urine sediment

643

3247

1.92

48.21

4.7

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

147

361

3.84

47.53

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

280

1027

2.59

46.05

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

237

799

2.81

45.93

2.5

2.4

g/l

38.0

39.1

1.73

193

720

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

296

1119

2.52

45.74

2.6

2.1

92.3

93.2

0.23

275

1016

(42529406) Shigella sp [Presence] in Stool by Culture

280

1033

2.58

45.51

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

276

1012

2.59

45.43

1.1

—

(3037756) Immunofixation for Serum or Plasma

171

481

3.36

45.19

1.6

1.9

—

(44790048)

137

332

3.89

45.14

1.6

1.5

—

(44790049)

137

332

3.89

45.14

1.6

1.5

—

(44790047)

137

332

3.89

45.14

1.6

1.5

—

(44806118)

137

332

3.89

45.14

1.6

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

186

553

3.18

44.95

5.5

5.2

iu/ml

482.7

427.9

0.10

(3008295) Osmolality of Serum or Plasma

104

206

4.74

44.40

1.5

mosm/kgh2o

280.0

278.3

0.33

170

(3007461) Platelets [#/volume] in Blood

6794

59651

2.14

43.96

28.1

11.7

e9/l

255.7

254.3

0.99

6667

57565

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

207

665

2.95

43.80

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

263

959

2.61

43.77

2.6

2.5

g/l

10.2

10.1

0.05

217

838

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5781

48617

1.54

43.51

4.2

3.1

mmol/l

1.3

1.2

20.92

5266

44897

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

282

1068

2.51

43.41

2.2

2.0

iu/l

5.4

4.3

0.88

119

440

(3039000) Anion gap in Blood

193

600

3.04

43.26

7.6

4.8

mmol/l

11.1

10.8

0.79

166

535

(3018572) Chloride [Moles/volume] in Blood

193

601

3.04

43.14

7.6

4.8

mmol/l

105.2

105.5

0.38

166

536

(3035941) MCH [Entitic mass]

6795

59720

2.12

42.84

28.0

11.6

30.3

0.03

6713

58689

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

10.41

42.72

1.6

1.2

ug/l

0.4

0.5

0.38

(3010813) Leukocytes [#/volume] in Blood

6797

59754

2.12

42.65

28.2

11.7

e9/l

6.8

6.3

49.19

6666

57480

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6101

52000

1.61

42.62

5.1

3.7

mmol/l

2.7

3.1

148.55

5602

48067

(3024731) MCV [Entitic volume]

6795

59732

2.11

42.61

28.0

11.6

91.0

90.6

11.57

6714

58696

(3026361) Erythrocytes [#/volume] in Blood

6795

59740

2.11

42.45

28.1

11.6

e12/l

4.5

41.70

6660

57484

(3000963) Hemoglobin [Mass/volume] in Blood

6795

59767

2.10

41.93

28.3

11.7

g/l

134.0

137.0

55.65

6715

58746

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.74

41.64

1.6

1.3

umol/l

112.1

166.9

0.28

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

178

543

3.10

41.22

1.6

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

225

785

2.72

40.87

2.7

2.4

g/l

0.0

0.35

202

740

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

139

368

3.56

40.34

1.4

1.2

nmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

115

5.95

40.03

5.1

3.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

172

524

3.10

39.93

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1749

11947

1.48

39.85

3.6

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

172

525

3.09

39.80

3.7

4.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

264

1012

2.48

39.61

2.5

2.2

187.7

174.2

1.68

255

952

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

149

425

3.30

38.56

1.4

1.2

nmol/l

0.3

0.1

0.44

(4015189)

8.98

38.48

3.2

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

221

790

2.65

38.29

1.2

1.3

titre

85.2

278.1

1.63

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

149

427

3.29

38.27

1.4

1.2

nmol/l

0.6

0.22

143

413

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

123

311

3.72

38.21

1.9

1.5

—

(3049717) Cytology report of Urine Cyto stain

302

1252

2.29

38.03

2.5

2.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

609

3254

1.81

37.91

1.3

1.2

iu/ml

114.0

158.4

2.35

236

1343

(4035726)

797

4613

1.68

37.36

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5993

51213

1.53

37.35

4.7

3.4

mmol/l

4.6

5.0

157.49

5534

47687

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5959

50865

1.53

37.28

4.7

3.4

mmol/l

1.5

1.6

54.67

5469

47256

(3009466) Valproate [Moles/volume] in Serum or Plasma

214

4.30

37.15

5.4

3.2

umol/l

347.1

363.1

0.43

179

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

207

730

2.68

36.84

2.7

2.5

g/l

0.0

0.70

184

687

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

407

1931

2.02

36.32

2.4

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

214

778

2.60

35.86

1.2

titre

896.0

912.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

201

4.34

35.73

1.9

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

237

909

2.47

35.53

3.5

4.1

mg/l

1.4

1.2

4.66

224

861

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

203

728

2.64

34.96

2.7

2.5

g/l

0.0

0.00

184

687

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

123

333

3.47

34.56

1.5

1.6

—

(3004451) EKG impression Narrative

8.01

34.50

1.3

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

134

385

3.28

34.31

1.4

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

203

4.20

33.59

1.2

u/ml

46.6

43.6

—

(3002385) Erythrocyte distribution width [Ratio]

5143

42961

1.40

33.48

22.6

10.0

13.8

13.5

25.54

5044

41865

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

132

382

3.25

33.42

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

224

4.02

33.39

1.8

3.6

e9/l

0.3

0.08

197

(3024522) Salmonella sp identified in Specimen by Organism specific culture

130

374

3.27

33.23

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

113

299

3.55

32.89

1.5

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

584

3214

1.75

32.73

3.2

2.1

ml/min/173m2

65.3

74.2

6.18

261

1080

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

129

373

3.25

32.71

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

119

331

3.38

32.10

1.5

1.4

g/l

33.3

38.3

3.56

109

315

(3011412) CD3 cells [#/volume] in Blood

118

327

3.39

32.01

1.8

3.1

e9/l

1.2

0.03

206

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

203

4.11

31.92

1.2

u/ml

34.5

11.5

—

(3017569) Oxygen content in Arterial blood

6.66

31.88

2.1

2.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

257

1075

2.27

31.70

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

193

710

2.57

31.60

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

130

386

3.17

31.58

1.6

mu/l

66.3

74.0

0.09

116

353

(3013139) Helicobacter pylori Ag [Presence] in Stool

538

2922

1.77

31.54

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1671

11750

1.42

31.36

1.7

1.5

mmol/l

1.4

1.3

8.04

1399

10143

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

369

3.21

31.31

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

110

296

3.49

31.23

3.3

3.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

232

3.84

31.06

1.8

3.5

e6/l

522.4

589.4

0.63

199

(3035637) Corticotropin [Mass/volume] in Plasma

141

444

2.99

30.99

1.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

126

373

3.18

30.77

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

125

372

3.16

30.26

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

145

4.65

30.22

2.1

1.6

mmol/24h

6.9

5.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

537

2975

1.73

29.32

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

191

729

2.47

28.98

1.2

1.1

u/ml

57.8

29.4

1.37

(3048929) Epstein Barr virus Ab [Presence] in Serum

273

1216

2.13

28.84

1.3

1.2

—

(3002256) Pathology report gross observation

1046

6825

1.50

28.83

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

151

4.46

28.78

1.7

1.1

u/l

5.9

6.5

0.25

127

(3004809) Band form neutrophils/100 leukocytes in Blood

136

439

2.91

28.64

2.7

3.3

1.7

1.8

0.07

113

354

(3021788) Differential panel - Synovial fluid

147

496

2.79

28.54

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

9.33

28.29

6.6

5.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

120

4.91

28.25

1.5

1.7

umol/l

1.9

0.00

115

(3044927) Protein electrophoresis panel - Urine

189

4.01

28.23

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1011

6579

1.50

28.18

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.96

28.13

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

242

3.60

27.80

1.9

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

108

310

3.27

27.77

1.5

1.4

e6/l

2543.1

2600.1

0.03

220

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

218

900

2.29

27.76

1.3

1.4

mg/l

519.1

525.6

0.05

208

851

(3011288) Drugs identified in Urine by Screen method

177

679

2.46

26.59

2.8

1.8

—

(3037121) Protein [Mass/volume] in Urine

255

1146

2.11

26.34

3.4

3.7

g/l

0.3

0.2

0.33

118

526

(3016038) Potassium [Moles/volume] in Urine

124

4.68

26.28

1.2

1.3

mmol/l

32.9

38.0

0.85

111

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

280

1306

2.03

26.18

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

150

538

2.62

25.91

1.4

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

9.32

25.86

2.3

1.2

ug/min

19.3

6.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

226

3.57

25.37

2.5

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

117

374

2.94

25.12

1.4

pmol/l

302.0

401.1

0.56

290

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

320

1590

1.91

24.95

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

182

3.86

24.81

2.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

4.25

24.51

2.0

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

108

335

3.02

24.45

1.6

1.4

55.5

0.00

194

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

4.46

24.41

2.1

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

126

428

2.77

24.22

1.9

1.8

mg/l

30.0

27.2

0.18

122

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

129

4.42

24.18

2.1

1.3

—

(3012441) Differential panel - Pleural fluid

275

3.24

24.14

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

479

7021

0.61

23.99

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

286

3.18

23.93

1.5

1.4

e6/l

113073.8

39139.6

0.65

167

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

177

716

2.33

23.68

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

132

465

2.67

23.67

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

166

653

2.39

23.65

1.6

1.5

e6/l

12997.8

11700.7

0.14

115

447

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

121

4.48

23.39

1.3

1.2

117.7

111.2

0.74

112

(3051611) Lipemic interference index of Serum or Plasma

105

329

2.99

23.38

3.5

2.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

114

375

2.85

23.27

1.2

1.1

u/ml

25.9

30.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

353

1852

1.81

23.19

3.0

2.2

e6/l

0.3

0.29

345

1792

(3009542) Hematocrit [Volume Fraction] of Blood

5669

49003

1.36

23.14

20.1

8.8

39.6

40.3

7.57

4115

38942

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

744

4727

1.52

23.00

4.1

4.6

ug/l

8.9

36.6

2.64

623

3735

(3045414) Leukocytes [Presence] in Urine

340

1769

1.82

22.95

1.9

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

247

3.30

22.83

4.5

2.4

mmol/l

6.7

6.0

1.25

206

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

184

769

2.25

22.82

1.3

1.4

mmol/l

3.7

3.5

2.64

172

725

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

428

2387

1.71

22.74

1.1

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

267

3.19

22.65

1.8

2.4

15.1

13.9

0.39

120

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

478

2.59

22.42

2.9

2.7

u/ml

3757.7

2418.0

—

(3044290) Cell count panel - Cerebral spinal fluid

183

771

2.24

22.27

1.5

—

(3017704) Immunofixation for Urine

115

4.47

22.13

1.4

2.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

115

394

2.74

21.79

1.2

1.1

—

80.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

287

1439

1.89

21.78

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

7.46

21.74

1.6

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

182

774

2.21

21.66

1.5

e6/l

64.5

21.1

0.65

139

596

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

182

774

2.21

21.66

1.5

e6/l

935.6

1430.9

0.44

147

626

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

164

671

2.30

21.41

1.3

u/ml

299.5

222.0

1.78

429

(3014271) Vancomycin [Susceptibility]

5.05

21.40

3.1

2.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.13

20.85

1.9

1.3

u/ml

1080.3

424.3

—

(3051651) Icteric interference index of Serum or Plasma

166

3.72

20.82

3.7

3.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.00

20.71

2.2

2.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

238

3.19

20.16

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

238

3.19

20.16

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

238

3.19

20.16

1.4

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.08

20.15

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

287

2.97

20.09

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

328

2.83

20.01

2.9

3.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

184

3.51

19.99

1.3

1.1

u/ml

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

4.00

19.96

1.3

1.2

g/l

0.3

1.10

108

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

9.72

19.95

2.4

2.5

mg/l

10.0

8.3

0.30

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

269

3.03

19.88

1.6

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

106

366

2.72

19.83

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

176

767

2.16

19.75

1.5

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

6.63

19.62

1.3

6.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

439

2.54

19.52

1.1

g/l

1.5

0.23

109

404

(3017354) Segmented neutrophils/100 leukocytes in Blood

268

3.00

19.40

2.7

3.6

62.3

57.0

1.17

186

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

113

409

2.59

19.27

1.2

1.1

—

19.1

—

(3045424) Erythrocytes [Presence] in Urine

155

648

2.25

19.27

1.6

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

117

4.15

19.11

1.7

1.8

umol/l

12.3

110.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

3.71

18.94

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

318

2.80

18.86

1.2

u/l

59.3

69.0

0.86

204

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

187

3.40

18.82

1.5

1.4

u/l

7.7

4.7

0.82

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

183

3.42

18.74

1.1

u/ml

11.0

9.3

0.12

(40768806) Pleura Pathology biopsy report

314

2.80

18.74

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

140

3.80

18.63

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

136

3.85

18.59

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

115

429

2.51

18.46

1.9

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

369

2092

1.67

18.44

1.1

titre

455.0

224.0

—

(3019977) pH of Arterial blood

113

4.13

18.29

1.8

2.2

7.4

0.22

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

240

1203

1.88

18.28

1.1

u/ml

1.9

6.3

2.38

225

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1787

13602

1.29

18.22

5.2

5.0

ug/l

2.7

3.6

0.82

1588

12435

(1002224) Polysomnography panel

343

1915

1.70

18.16

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

170

3.46

17.97

1.1

u/l

92.8

74.6

0.37

138

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

1098

1.91

17.94

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

189

885

2.01

17.58

2.0

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.42

17.53

2.2

1.3

mg/l

65.3

63.4

0.09

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

730

4866

1.44

17.52

2.1

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.78

17.51

1.5

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

3.43

17.42

1.1

u/l

35.5

17.6

0.38

132

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

3.53

17.36

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.46

17.34

2.5

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

152

3.56

17.29

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

334

2.66

17.21

2.0

2.6

40.6

35.5

0.54

(3017446) Testosterone [Moles/volume] in Serum or Plasma

506

3146

1.53

17.19

2.2

1.9

nmol/l

11.6

13.3

4.28

423

2832

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.41

17.11

1.5

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.00

17.08

1.6

1.2

54.1

61.9

0.46

(3045716) Anion gap in Serum or Plasma

107

4.10

17.05

2.2

2.6

mmol/l

8.6

8.9

0.20

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

161

719

2.10

17.03

1.5

1.3

u/ml

126.4

108.0

0.37

158

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

310

2.72

16.97

1.2

1.1

mg/l

41.1

42.5

0.10

254

(3004775) Volume in Urine collected for unspecified duration

5.09

16.94

2.7

2.1

725.3

621.1

0.59

(3044242) Glucose [Moles/volume] in Arterial blood

4.40

16.69

2.0

2.2

—

(3045788) Cell count panel - Pleural fluid

245

2.90

16.22

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

104

4.04

16.02

1.7

2.8

e6/l

181.3

293.0

0.93

(4094501)

208

1042

1.88

15.91

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

232

1203

1.82

15.91

1.3

1.4

u/l

13.4

11.2

1.20

186

989

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

723

4893

1.41

15.90

1.8

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

218

3.00

15.88

1.5

ug/l

7.0

8.0

0.29

198

(3010375) cycloSPORINE [Mass/volume] in Blood

4.34

15.63

22.9

31.3

ug/l

110.3

130.5

0.97

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.87

15.55

1.6

1.5

mg/l

2.0

4.2

0.60

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.87

15.55

1.6

1.5

mg/l

1.2

1.0

0.17

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

6.99

15.43

5.8

9.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

798

5521

1.39

15.40

2.2

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

4.12

15.39

1.6

1.4

pmol/l

14.2

14.0

0.10

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

233

2.89

15.28

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

233

2.89

15.28

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

233

2.89

15.28

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

228

2.91

15.28

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

228

2.91

15.28

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

228

2.91

15.28

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

219

2.94

15.16

1.3

1.2

titre

185.0

77.7

0.61

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

200

3.04

15.07

1.2

1.1

nmol/l

15.9

15.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

170

811

1.97

15.06

1.2

1.1

au/ml

12.9

10.2

0.19

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

272

2.72

14.96

1.3

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

173

3.19

14.83

2.8

2.7

mu/l

22.9

17.1

0.71

163

(44816559) Phosphatidylethanol [Mass/volume] in Blood

110

446

2.31

14.80

1.3

1.2

—

(3011648) Oxygen content in Venous blood

183

3.11

14.77

2.7

5.3

11.3

11.2

0.01

183

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

2.99

14.70

1.0

1.1

u/l

1.0

0.63

103

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

228

2.87

14.70

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.91

14.65

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

249

2.78

14.64

2.6

2.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

189

3.06

14.62

1.5

1.2

u/l

12.8

13.2

0.10

183

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

304

2.58

14.44

1.1

mg/l

274.9

270.3

0.07

270

(3000093) Morphology [Interpretation] in Blood Narrative

272

2.68

14.43

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

231

2.83

14.37

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

102

408

2.34

14.17

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

233

2.81

14.15

1.0

1.1

mg/l

279.6

288.1

0.52

214

(3008898) HLA-B27 [Presence]

272

1529

1.68

14.09

1.1

—

(3012565) Volume of 24 hour Urine

132

3.46

14.09

1.7

2.1

2166.0

2036.0

0.29

124

(40768443) Skin Pathology biopsy report

332

1966

1.60

13.99

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.97

13.92

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

195

2.97

13.88

1.2

1.1

—

(3016750) Collection duration of Urine

4.82

13.76

2.8

2.2

min

486.8

499.2

0.21

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

279

2.61

13.75

1.9

3.1

e6/l

817.6

748.8

0.29

100

(3035880) pH of Pleural fluid

121

3.55

13.71

1.5

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

5.63

13.67

1.5

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

113

3.63

13.58

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

113

3.63

13.58

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

388

2398

1.53

13.56

1.3

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.98

13.50

6.0

9.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

6.61

13.47

2.0

1.1

mg/l

9.9

10.5

0.15

(3023410) Appearance of Cerebral spinal fluid

383

2.35

13.44

1.8

1.7

—

(3028433) Virus identified in Specimen by Culture

3.98

13.33

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

226

2.77

13.24

2.2

2.9

40.9

37.5

0.55

(37021550) Renin [Units/volume] in Plasma --upright

4.91

13.17

1.3

1.5

mu/l

46.7

63.0

0.28

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

266

2.60

12.94

1.3

mmol/l

2.1

1.9

0.58

252

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

126

3.41

12.92

1.7

umol/l

29.7

28.5

0.44

120

(3016879) Cocaine [Presence] in Urine

221

1203

1.73

12.91

1.9

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

9.31

12.85

1.8

1.0

—

(4027681)

225

2.74

12.80

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.85

12.43

2.4

1.6

umol/l

49.2

44.5

0.20

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

102

433

2.20

12.38

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

152

748

1.91

12.37

1.2

—

(4198724)

5.45

12.21

1.3

6.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

3.51

12.07

3.1

3.0

umol/l

27.8

27.5

0.06

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.30

12.03

12.5

3.8

mmol/l

5.0

6.4

0.78

(44813793)

310

2.41

11.99

1.1

—

(4306422)

123

571

2.02

11.86

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

120

3.34

11.76

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

123

573

2.01

11.75

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

194

1051

1.73

11.57

1.2

1.1

u/ml

1.7

1.4

0.10

399

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

113

514

2.06

11.53

1.3

1.2

u/ml

4.9

3.9

0.23

213

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

148

743

1.87

11.37

1.5

1.3

u/l

27.5

32.2

0.87

117

618

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

118

552

2.00

11.17

1.3

1.2

u/ml

1.8

2.7

0.99

176

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

728

1.87

11.15

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

120

3.26

11.09

1.8

1.7

nmol/l

2.9

2.4

0.18

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.01

11.04

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

250

2.50

10.92

1.3

titre

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.41

10.85

1.7

1.4

ng/l

90.9

78.5

0.22

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

240

2.53

10.83

1.7

1.4

42.2

37.9

0.34

133

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

507

6334

0.72

10.83

1.7

—

(3022621) pH of Urine by Test strip

407

2665

1.44

10.72

2.9

2.1

—

(3042733) HLA Ab [Presence] in Serum

4.66

10.72

5.0

4.2

—

(3042517) Benzodiazepines panel - Urine

23.26

10.70

1.5

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

168

897

1.76

10.58

1.2

1.1

u/ml

2.6

2.4

0.03

211

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.75

10.50

1.2

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.26

10.41

1.1

1.2

umol/24h

0.8

0.7

0.66

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

403

2.13

10.40

1.1

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

142

725

1.84

10.38

1.8

1.7

pmol/l

191.3

207.7

1.07

130

693

(3016650) Hepatitis A virus Ab [Presence] in Serum

116

555

1.96

10.33

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.66

10.29

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.56

10.28

1.2

g/l

42.4

39.0

0.61

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

115

550

1.96

10.26

1.2

1.1

119.9

117.1

0.42

106

486

(3047007) Chlamydophila sp Ab [Presence] in Serum

144

742

1.82

10.23

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

310

2.29

10.22

2.2

2.6

nmol/l

18.3

18.9

0.17

304

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

156

827

1.77

10.09

3.3

3.7

u/ml

74.2

522.2

2.22

133

761

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

153

2.87

10.00

1.2

1.1

ng/l

167.9

406.2

0.76

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

322

2.23

9.78

1.1

iu/ml

10.3

9.2

0.17

(3010144) Erythrocytes [#/volume] in Synovial fluid

242

2.43

9.70

1.4

1.2

e6/l

136941.9

82048.1

0.17

167

(3021387) Prolactin [Units/volume] in Serum or Plasma

252

1528

1.55

9.68

1.7

1.6

mu/l

354.5

272.1

2.01

228

1385

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.99

9.58

1.1

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

119

590

1.89

9.57

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

147

779

1.77

9.54

1.2

1.1

u/ml

3.4

4.3

0.33

279

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

4.89

9.53

3.6

1.1

mmol/l

7.1

7.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

578

1.89

9.52

1.6

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.36

9.52

1.7

3.1

umol/l

14.1

18.3

0.69

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

2.72

9.50

1.9

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

490

1.97

9.37

1.3

1.4

u/l

49.2

34.4

0.33

417

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.70

9.29

1.4

1.2

ug/l

560.6

193.5

0.37

(3014891) Appearance of Pleural fluid

6.20

9.25

2.7

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

253

1556

1.53

9.14

3.4

3.9

u/ml

402.1

2304.6

1.84

208

1333

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.65

9.12

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

167

938

1.67

8.83

1.2

1.1

u/ml

4.9

5.0

0.02

477

(3000764) Benzodiazepines [Presence] in Urine

227

1379

1.55

8.69

1.9

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.70

8.66

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

250

2.31

8.62

1.5

1.3

—

(3027008) Opiates [Presence] in Urine

229

1397

1.54

8.61

1.9

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

434

1.98

8.61

2.3

2.6

—

(3028300) Cannabinoids [Presence] in Urine

229

1398

1.54

8.58

2.0

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

334

4299

0.71

8.53

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

4.12

8.52

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.82

8.38

1.3

pmol/l

267.9

351.8

0.48

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

395

2.01

8.31

1.4

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1400

11177

1.20

8.31

4.5

4.1

20.9

21.1

0.14

645

5572

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

190

1121

1.59

8.28

1.8

1.6

nmol/l

44.1

44.0

0.01

184

1090

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

8.53

8.22

1.0

u/l

8.0

24.6

0.55

(3036071) Salmonella sp Ab [Titer] in Serum

119

2.90

8.11

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.25

8.10

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

451

1.93

8.06

1.5

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

159

904

1.65

8.06

1.1

u/ml

0.6

0.9

0.66

381

(3023430) Cat dander IgE Ab [Units/volume] in Serum

136

742

1.72

8.04

1.2

1.0

u/ml

3.0

4.0

0.43

274

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

189

2.47

8.04

1.9

1.7

u/field

3.1

4.2

0.29

135

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

271

2.20

7.97

2.0

1.9

mg/l

4.7

3.2

0.89

264

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

136

2.74

7.93

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.39

7.92

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

4.33

7.90

1.5

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.58

7.83

3.5

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.34

7.78

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

176

2.49

7.72

3.2

1.5

mg/l

26.9

9.9

0.69

109

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

6.36

7.68

6.4

9.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

409

1.94

7.57

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

114

2.86

7.52

1.1

89.7

92.7

0.27

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

230

2.27

7.52

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

2.30

7.47

1.2

1.6

u/ml

21.7

20.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.66

7.41

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

100

512

1.83

7.38

3.4

2.0

mmol/l

1.4

1.3

0.41

499

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

122

663

1.72

7.36

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.36

7.30

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

257

2.18

7.30

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

137

2.65

7.30

1.1

u/ml

8.1

6.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

234

2.23

7.24

1.1

—

(3027944) Amphetamines [Presence] in Urine

221

1391

1.49

7.24

1.8

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

182

2.41

7.21

1.4

1.2

umol/l

4.1

4.7

0.56

173

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

754

5733

1.25

7.17

1.5

1.4

—

(3034426) Prothrombin time (PT)

107

2.87

7.16

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

2.92

7.16

2.0

4.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

114

2.78

6.96

3.5

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

263

1726

1.43

6.95

2.1

u/l

5237.4

5653.8

0.07

733

(4268621)

363

1.95

6.95

2.5

2.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

130

2.65

6.94

1.6

1.4

3.2

2.6

—

(3022689) Creatine [Moles/volume] in Urine

3.76

6.93

1.2

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

109

585

1.74

6.90

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.65

6.89

1.3

1.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.39

6.85

1.2

mmol/l

0.6

2.2

0.63

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.59

6.82

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

3.59

6.82

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.59

6.82

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.59

6.82

1.2

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.07

6.81

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

2.77

6.72

1.2

1.1

88.5

95.0

0.40

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.81

6.71

7.7

2.3

pmol/l

57.9

20.2

—

(3006270) Folate [Moles/volume] in Blood

285

2.06

6.70

1.1

nmol/l

399.4

380.0

0.30

262

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

166

2.41

6.67

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

166

2.41

6.67

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

166

2.41

6.67

1.7

1.9

—

(4024509)

344

1.95

6.60

1.8

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

167

2.40

6.59

1.7

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

251

2.12

6.51

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

109

596

1.71

6.48

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

2.33

6.47

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.26

6.39

1.0

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

149

887

1.57

6.35

2.2

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.76

6.29

1.6

1.7

—

(3011436) Histone Ab [Units/volume] in Serum

3.68

6.12

1.0

1.1

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.06

6.10

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

140

2.46

6.02

1.1

u/ml

1.5

10.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.36

6.00

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

444

1.79

5.96

1.1

—

(3047189) Immunofixation for 24 hour Urine

130

2.51

5.92

2.1

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.25

5.91

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

206

2.17

5.89

1.1

ratio

1.1

1.0

0.35

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

262

2.03

5.86

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

120

2.56

5.83

1.5

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.49

5.80

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

264

2.01

5.75

1.8

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.20

5.74

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

114

653

1.63

5.74

1.1

1.0

u/ml

0.3

0.2

0.02

129

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

277

1.99

5.73

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

233

2.08

5.73

2.0

1.3

mmol/l

6.9

5.7

1.35

172

(3003694) ABO and Rh group [Type] in Blood

1756

14663

1.15

5.73

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

105

2.66

5.72

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.64

5.72

1.6

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

137

822

1.56

5.69

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

234

2.07

5.67

2.1

1.5

—

(40768446) Kidney Pathology biopsy report

2.73

5.43

1.7

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

2.62

5.39

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

2.62

5.39

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

142

872

1.52

5.34

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

142

873

1.52

5.31

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

266

1.96

5.30

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

306

1.89

5.25

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.65

5.17

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

2.61

5.16

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.15

5.15

1.4

2.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

5.47

5.10

1.3

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.06

1.6

0.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

5.06

1.6

0.0

mg/l

23.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

183

1196

1.43

5.06

1.9

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

546

1.64

5.02

1.1

—

(3024932) HLA-DR beta [Type]

2.71

4.96

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

154

2.24

4.94

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

154

2.24

4.94

1.4

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

488

1.66

4.82

3.7

2.1

mmol/l

7.1

6.4

1.71

480

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

2.29

4.82

1.8

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

138

2.29

4.82

1.8

2.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

613

4760

1.21

4.80

1.7

1.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.46

4.75

2.6

2.4

mmol/l

1.2

0.07

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

2.28

4.74

1.8

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.29

4.70

2.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.58

4.67

3.2

3.4

—

9.5

—

(3024471) HLA-A [Type]

2.61

4.66

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

343

2507

1.28

4.62

1.9

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.72

4.60

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

147

2.22

4.59

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

268

1.88

4.55

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.13

4.51

1.1

1.0

—

(40768441) Liver Pathology biopsy report

289

1.84

4.50

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

173

2.10

4.49

1.1

90.6

91.4

0.06

138

(3000012) Reticulocyte production index

155

2.16

4.46

1.3

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.62

4.43

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.16

4.42

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

13.01

4.38

1.1

1.2

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

13.01

4.38

1.1

1.2

mmol/l

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.78

4.37

1.9

1.3

5.9

16.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.40

4.36

1.2

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

9.30

4.30

1.1

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.54

4.25

1.0

1.2

u/ml

2.5

10.9

0.70

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.32

4.21

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.94

4.16

1.3

1.8

—

(3018133) Calcium [Moles/volume] in Urine

2.62

4.16

2.2

mmol/l

2.4

2.7

0.35

(3037556) Urate [Mass/volume] in Serum or Plasma

2.55

4.11

1.8

1.4

—

(44806420)

4.43

4.08

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.24

4.07

1.3

ng/l

92.8

125.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

252

1.85

4.05

1.3

1.2

umol/l

62.4

71.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

168

2.05

4.04

1.2

u/l

72.6

71.0

0.06

146

(3030313) Adrenal Ab [Titer] in Serum

3.56

4.03

1.4

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

2.11

4.00

2.2

2.5

umol/l

44.2

52.5

1.26

136

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

144

2.13

3.99

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

429

3277

1.23

3.99

2.0

1.8

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.04

3.92

1.0

1.1

u/ml

0.0

7.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

164

2.04

3.91

1.3

1.2

u/l

15.5

16.5

0.10

136

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.72

3.85

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.72

3.85

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

3.79

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

528

1.55

3.79

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

117

2.23

3.77

1.1

u/ml

3.4

10.7

0.50

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.36

3.72

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

136

2.12

3.72

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

1.85

3.72

1.3

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.64

3.65

1.1

1.2

nmol/l

120.0

150.1

0.42

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

6.76

3.65

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

107

2.26

3.64

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

360

1.66

3.60

1.4

1.2

—

(3024263) Appearance of Synovial fluid

138

2.09

3.60

1.8

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.13

3.59

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

132

2.12

3.58

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.47

3.57

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.47

3.57

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.47

3.57

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

537

1.53

3.54

1.2

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.20

3.47

3.8

6.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

253

1.77

3.42

2.9

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

247

1.77

3.39

2.1

1.7

u/field

2.2

0.01

110

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.68

3.38

1.1

u/ml

0.0

0.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

7.23

3.37

5.7

8.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

310

1.68

3.37

1.3

1.4

mmol/l

9.8

12.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.28

3.33

1.3

1.2

46.7

67.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.85

3.32

2.8

2.9

mmol/l

1.2

0.78

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.38

3.32

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.96

3.31

1.0

1.1

u/ml

0.4

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.92

3.29

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

4.92

3.29

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

110

716

1.43

3.25

1.1

u/ml

1.5

4.1

4.21

431

(3009015) Lactate [Moles/volume] in Synovial fluid

3.41

3.23

1.1

1.2

mmol/l

7.5

6.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

2.04

3.21

1.1

—

(4034850)

190

1358

1.31

3.15

12.6

4.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.58

3.13

2.2

2.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

134

2.01

3.09

1.1

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

109

2.13

3.09

1.1

1.3

3.4

17.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

229

1682

1.27

3.08

1.3

miu/ml

280.4

228.5

1.05

899

(3045142) Bone marrow Pathology biopsy report

469

1.51

2.97

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.36

2.96

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

996

0.67

2.95

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.20

2.94

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.20

2.94

5.9

5.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.63

2.91

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

230

2659

0.80

2.90

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

586

1.45

2.89

2.1

2.4

umol/l

4.7

6.5

1.00

447

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.71

2.87

1.0

1.1

u/ml

0.0

1.6

—

(3048879) Bone marrow aspiration report

2.22

2.87

1.7

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1005

8445

1.12

2.85

3.0

ug/l

0.7

0.8

4.66

649

5402

(3000330) Specific gravity of Urine by Test strip

243

1822

1.25

2.78

3.4

2.5

—

(3006462) Nitrate [Presence] in Urine

161

1.85

2.71

3.9

2.2

—

(3001556) Androgen free Index in Serum or Plasma

3.21

2.69

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

2.08

2.69

1.1

1.4

—

(44806071)

3.01

2.69

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

136

1.92

2.64

2.3

3.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1164

0.71

2.60

1.8

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

112

1.99

2.54

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

279

1.60

2.48

3.5

2.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

146

1.85

2.48

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.84

2.46

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

363

2873

1.18

2.44

1.4

1.3

iu/l

28.5

32.8

1.59

317

2557

(21494814) CD8 cells/100 lymphocytes in Specimen

147

1.84

2.43

1.9

2.1

—

(3051101) Glucose [Moles/volume] in Cord blood

4.34

2.43

4.4

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.64

2.42

1.2

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.46

2.40

1.0

1.1

u/ml

0.2

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.07

2.39

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.76

2.35

1.1

1.2

umol/24h

1.6

1.5

0.09

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

121

852

1.32

2.32

1.4

nmol/l

0.3

0.4

1.02

662

(3038177) Helicobacter pylori Ab [Presence] in Serum

124

877

1.32

2.31

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.07

2.31

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

390

1.48

2.29

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.65

2.25

1.3

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.65

2.25

1.2

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

172

1.73

2.24

1.7

1.4

—

(4211845)

179

1.72

2.24

4.1

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1207

0.74

2.24

1.4

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.05

2.20

3.3

7.6

u/l

55.8

48.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.54

2.20

1.3

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.10

2.20

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.83

2.20

1.1

21.6

22.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.83

2.20

1.0

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.83

2.20

1.1

36.2

35.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.38

2.18

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.38

2.18

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.29

2.13

1.3

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.29

2.13

1.2

1.1

nmol/l

259.1

287.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.98

2.11

1.5

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

5.16

2.09

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.08

2.05

1.6

1.2

16.3

41.8

4.78

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1178

0.75

2.04

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.88

2.03

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.98

2.01

1.2

2.8

—

(3026480) Teichoate Ab [Titer] in Serum

3.42

1.99

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.42

1.99

1.0

—

(3036603) Volume of Urine

222

1.59

1.99

1.6

1.5

1657.0

2096.9

—

(3005033) Fetal Nuchal fold Thickness US

1171

0.76

1.97

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.65

1.95

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.28

1.94

1.0

1.1

u/ml

0.0

3.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

554

0.65

1.94

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

283

1.51

1.93

1.3

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.11

1.89

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

332

0.56

1.87

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

205

1.59

1.83

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.90

1.82

1.3

1.4

e6/l

13256.5

4574.7

0.37

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.10

1.81

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.10

1.81

6.1

2.4

mmol/l

0.8

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

209

2309

0.84

1.80

1.4

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.38

1.80

3.2

1.7

u/field

0.5

0.9

0.50

(3044007) Cell count panel - Peritoneal fluid

101

1.84

1.76

1.3

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.96

1.73

1.6

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.23

1.72

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.32

1.72

2.6

3.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.02

1.71

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.87

1.70

1.2

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.87

1.70

1.0

1.9

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.87

1.70

1.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

3.28

1.70

1.2

1.3

—

(3025315) Body weight

3.28

1.70

4.7

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

110

1.78

1.66

1.3

1.5

e6/l

526.2

1563.1

1.67

(3039443) Prostate specific Ag panel - Serum or Plasma

1067

0.77

1.66

1.5

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.83

1.65

3.4

6.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.27

1.65

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

189

1.58

1.64

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.88

1.61

2.0

1.5

ug/l

7.4

8.6

0.95

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

110

1279

0.80

1.60

1.5

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.79

1.45

1.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

667

0.74

1.43

1.1

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.21

1.43

1.0

ug/l

111.2

85.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

123

1.66

1.42

1.0

1.2

—

1320.0

—

(3033799) Differential panel - Peritoneal fluid

1.76

1.42

1.8

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.10

1.41

2.6

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

138

1.62

1.40

1.0

—

(4038314)

2.65

1.38

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.41

1.37

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.41

1.37

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.16

1.36

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.16

1.36

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

2111

20378

0.95

1.36

2.7

2.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

253

1.43

1.34

1.0

ng/l

852.7

697.8

1.12

175

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

262

1.42

1.32

1.8

—

(4212803)

2.40

1.30

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

255

1.42

1.30

1.0

ng/l

313.5

369.4

0.54

188

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

256

1.42

1.28

1.0

ng/l

48.7

45.7

0.14

184

(3019897) Erythrocyte distribution width [Ratio] by Automated count

924

0.79

1.27

4.1

2.1

13.1

0.06

910

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.25

1.25

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.42

1.25

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

123

949

1.21

1.24

4.7

2.5

mg/l

24.1

27.0

0.30

562

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

371

0.67

1.24

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.86

1.22

3.6

2.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.81

1.21

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.32

1.18

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.02

1.17

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

222

1.42

1.16

2.1

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.86

1.14

1.7

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

132

1.55

1.12

2.8

2.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.32

1.12

2.7

2.5

—

(3003338) MCHC [Mass/volume]

5079

46500

1.05

1.10

24.0

10.1

g/l

332.0

333.0

14.02

5035

46110

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

139

1511

0.85

1.10

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

161

1728

0.86

1.09

1.5

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

257

1.38

1.08

2.1

1.9

ug/l

2.0

3.5

2.39

228

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.32

1.05

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.32

1.05

1.0

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.75

1.04

1.3

1.1

—

(21494434) Karyotype in Bone marrow

319

1.31

0.98

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.70

0.96

1.5

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

169

1.43

0.95

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

108

1.55

0.94

1.3

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

256

2141

1.11

0.94

1.8

1.4

mg/l

3.3

2.8

0.43

185

1336

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.82

0.91

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

349

1.28

0.89

1.1

u/ml

0.5

2.8

1.76

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.69

0.87

3.4

2.6

u/l

6670.2

822.2

0.41

(3025577) Chromium [Mass/volume] in Blood

252

1.33

0.87

2.1

2.0

ug/l

1.5

2.7

2.84

209

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

318

1.29

0.86

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.61

0.86

1.5

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

111

887

1.16

0.83

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

151

1.42

0.82

1.4

1.3

—

(3019174) dRVVT (LA screen)

1.86

0.80

1.2

—

(4281824)

668

0.82

0.80

1.2

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.69

0.79

2.4

3.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

390

3362

1.08

0.79

1.8

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

202

1.33

0.75

1.1

miu/ml

1414.6

1370.1

0.08

202

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

233

1970

1.10

0.74

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.74

2.9

3.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

134

1406

0.88

0.73

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

134

1406

0.88

0.73

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

134

1398

0.89

0.68

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

410

0.79

0.67

1.6

mmol/l

7.4

7.3

0.07

259

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

135

1400

0.89

0.63

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.58

0.62

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

108

1131

0.89

0.61

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

121

1.38

0.60

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

671

1.15

0.59

1.3

mmol/l

7.1

6.5

1.25

496

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.57

0.59

1.1

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.64

0.56

1.0

mmol/l

8.5

8.3

—

(3017509) Phencyclidine [Presence] in Urine

1.55

0.53

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.53

3.7

2.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

261

1.21

0.47

6.0

5.7

u/ml

43.5

13451.4

—

(3009871) Measles virus Ab [Titer] in Serum

146

1.27

0.42

1.6

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

113

1.32

0.42

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.55

0.42

1.8

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.41

0.38

3.8

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1073

10211

0.97

0.38

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

355

3150

1.05

0.38

2.4

3.7

u/ml

33.4

45.5

1.20

342

3064

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.33

0.37

1.3

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.36

0.34

1.7

1.0

—

(3020650) Glucose [Presence] in Urine

127

1.24

0.32

2.1

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

356

1.12

0.28

1.1

u/ml

0.6

2.0

1.37

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

158

1388

1.06

0.27

1.3

1.5

pmol/l

111.3

110.2

0.02

152

1357

(1761482) Bacteria [#/volume] in Urine by Culture

832

1.07

0.26

4.9

2.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

693

1.07

0.23

1.4

ug/l

3.9

4.5

0.15

605

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

141.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

8.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

337

1.10

0.21

1.1

u/ml

0.2

2.7

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.20

0.0

2.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

144

0.84

0.20

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.19

0.19

1.2

1.3

—

(40768793) Breast Pathology biopsy report

162

1445

1.04

0.19

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

390

1.07

0.14

1.5

1.3

pmol/l

88.5

65.2

0.48

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

219

1979

1.03

0.14

1.4

1.8

—

(3025130) Human papilloma virus identified in Specimen

857

1.04

0.12

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.83

0.08

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.81

0.07

25.3

4.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.83

0.07

1.4

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.04

0.07

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

128

0.94

0.02

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

266

1.01

0.00

1.9

1.6

—

(4133840)

117

1.03

0.00

1.5

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

124

0.97

0.00

3.2

3.4

ng/l

81.0

103.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.86

0.00

1.2

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

100.4

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

79.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.93

0.00

1.0

1.1

mmol/l

21.1

19.3

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.2

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

158.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint VOCALCORDDYS and mortality.

Females

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.737 [1.58, 1.91]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.223

During the follow-up period (1.1.1998 — 31.12.2019), 3227 out of 21177 females with VOCALCORDDYS died.

Males

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.823 [1.66, 2.0]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 3762 out of 15769 males with VOCALCORDDYS died.

Mortality risk

Mortality risk for people of age

years, who have VOCALCORDDYS.

N-year risk	Females	Males
1	0.158%	0.418%
5	1.028%	2.325%
10	2.726%	5.509%
15	4.727%	10.609%
20	8.034%	17.177%

Relationships between endpoints

↥

Index endpoint: VOCALCORDDYS – Vocal cord dysfunction

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vocal cord dysfunction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints